WO2005075996A1 - Baseboard for constructing surface plasmon resonane antibody array sensor and method of constructing the same - Google Patents
Baseboard for constructing surface plasmon resonane antibody array sensor and method of constructing the sameInfo
- Publication number
- WO2005075996A1 WO2005075996A1 PCT/JP2005/001579 JP2005001579W WO2005075996A1 WO 2005075996 A1 WO2005075996 A1 WO 2005075996A1 JP 2005001579 W JP2005001579 W JP 2005001579W WO 2005075996 A1 WO2005075996 A1 WO 2005075996A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibody
- protein
- surface plasmon
- plasmon resonance
- array sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
Definitions
- the present invention relates to a substrate for producing a surface plasmon resonance antibody array sensor and a method for producing the same.
- the present invention relates to a substrate for producing an antibody array sensor based on surface plasmon resonance, an antibody array sensor based on surface plasmon resonance using the same, and a method for producing them.
- a planar solid substrate prepared by binding hundreds of thousands of different biomolecules to specified individual microregions on a surface several centimeters square is used as an array or The power of what is referred to as a chip
- the biomolecules that exist in a vast and diverse manner in a living unit such as a cell in recent years and constitute a system (genome when referring to genes, proteome when referring to proteins)
- genomics or proteomics which aims to conduct a comprehensive and comprehensive analysis of the information, is becoming increasingly important.
- the array technology integrates the detection of molecular bonding phenomena in a narrow area of a planar solid substrate (substrate) at a high level, thereby enabling high-speed and comprehensive analysis using an extremely small amount of biomolecule samples. It offers the possibility of performing a specific method, but on the other hand, the detection technology essential for this technology has been required to detect the binding phenomena of molecules extremely limited in quantity with high sensitivity . In fact, in genomic analysis, which is an advanced application of this array technology, a gene (DNA molecule) to be contacted is labeled with a fluorescent molecule capable of generating fluorescence.
- the presence or absence of binding to a specific gene immobilized on the DNA array is determined by irradiating the microregion where the gene is immobilized with a high-energy laser with the excitation wavelength of the fluorescent molecule to generate fluorescent light.
- a high-energy laser with the excitation wavelength of the fluorescent molecule to generate fluorescent light.
- Proteome analysis has rushed to follow.
- an array technology that has demonstrated its power in genomic analysis has been adopted in order to exhaustively and comprehensively analyze a vast and diverse variety of biomolecules.
- a protein array or an antibody array developed from the analogy of a DNA array has a new powerful problem that does not occur in a DNA array. That is, 1) the binding reaction of proteins is relatively weak compared to that of DNA, so the amount bound per unit area of the detection surface is reduced.2) Basically, linear molecules remain In the DNA to be bound, the interference with the binding phenomenon can be neglected if the fluorescent molecule labeling or immobilization on the surface is performed using the molecular ends avoiding the center of the chain contributing to the binding, For proteins whose linear macromolecules form a three-dimensional structure, the labeling site or immobilization site in the protein varies, and often overlaps with the site essential for protein binding function.
- Bound fluorescent molecules or molecular binding sites for immobilization can significantly inhibit the binding phenomena themselves.
- serious problems arise in the measurement of protein arrays or antibody arrays, in which effective sensitivity is not practically obtained, or measurement is performed at the lower end of the effective detectable range, resulting in lack of reproducibility.
- this has become a factor that has not spread as much as NA arrays.
- Surface plasmon resonance sensor is made of metal (mainly gold)
- the glass-side force on a thin film of a thin film deposited on the glass the visible light is totally reflected, and at that time, the wave number (frequency) of the quantum wave called the evanescent wave that seeps into the interface between glass and metal and the medium in contact with the metal
- the wave numbers of surface plasmon waves coincide, energy absorption called surface plasmon resonance occurs and the reflected light diminishes.
- It is a sensor that can monitor the change in mass on the surface by measuring the resonance angle at which the change in the refractive index causes dimming.
- a surface plasmon resonance type sensor it is possible to use this metal surface by dividing it into a large number of divided specific regions, and by immobilizing molecules in each specific region, an array sensor is obtained. Function can be exhibited.
- this array sensor can measure unlabeled molecules, so that labeling with fluorescent molecules is not necessary, but sensitivity is in principle lower than that of the detection method using fluorescent labeling.
- the adoption of the surface plasmon resonance method has not achieved a drastic improvement in effective sensitivity.
- the present invention relates to the improvement of the amount of binding per unit area of the above problem 1) in the conventional array sensor, particularly the practically useful antibody array sensor, and the improvement of the protein immobilization in the above problem 2).
- the aim is to provide a radical solution for overcoming binding function inhibition.
- the present invention provides an antibody array sensor, in which an antibody-binding protein is used as an antibody molecule immobilizing means, the orientation of which is immobilized on a planar substrate surface at one carboxy terminus of a protein main chain.
- the present inventors firstly formed an amide bond formation reaction via a cyanocysteine residue on the surface of each minute region on a planar substrate also serving as a detection unit used in an array sensor.
- a planar substrate also serving as a detection unit used in an array sensor.
- the antibody recognition protein which has been ordered and immobilized via the carboxyl group at the carboxy terminus of the protein backbone, using as a scaffold for immobilization of the antibody molecule, and aligning the same antibody recognition molecule.
- it can be standardized between domains.
- the present invention was completed by developing an application to a fully automatic measurement system based on a sensor that can automatically and repeatedly perform measurement using various antibody molecules ⁇
- An array substrate for producing a surface plasmon resonance antibody array sensor wherein an antibody-binding protein or peptide is aligned and fixed in a specific region on the surface of a detection section.
- a surface plate characterized in that antibody proteins are aligned and immobilized on a substrate on which antibody-binding proteins or peptides are aligned and immobilized in a specific region on the detection surface. Rasmon resonance antibody array sensor.
- An antibody-binding protein is obtained by immobilizing the carboxy terminus of a peptide via a linker sequence with a linker molecule on a sensor detection unit having a primary amino group with an amide bond, and Equation (1)
- An array substrate for producing a surface plasmon resonance antibody array sensor characterized by being represented by:
- R is the amino acid sequence of the antibody-binding protein or peptide, and R is any
- An array substrate for producing a surface plasmon resonance antibody array sensor comprising:
- R represents an amino acid sequence of a protein or peptide.
- R represents the amino acid sequence of the antibody-binding protein or peptide; It represents an amino acid sequence that is strongly negatively charged in the vicinity and can make the isoelectric point of the protein or peptide represented by the general formula (3) acidic.
- a peptide or a carboxy terminus of the protein main chain of the general formula (3) is bonded to a protein or peptide represented by the formula below and a primary amino group of a linker molecule on the sensor, and then the antibody is bound by the antibody-binding protein or peptide.
- a surface plasmon resonance antibody array sensor wherein the linker molecule having a primary amino group (7) is a molecule containing a polymer compound having a primary amino group represented by the general formula (2): Array substrate for fabrication.
- an antibody array sensor in which antibody molecules have a high density and antibody proteins are immobilized in a controlled orientation on the surface of an array substrate such as a metal used for a surface plasmon resonance apparatus. If the antibody array sensor of the present invention is used in the detection section of the surface plasmon resonance sensor, the effective sensitivity is extremely remarkably increased as compared with the conventional antibody array, and the practicality of the antibody array sensor is improved. Enlargement can be achieved.
- an antibody-binding protein is adsorbed to a primary amino group of a linker molecule on the surface of a detection metal of a surface plasmon resonance array sensor capable of detecting an unlabeled molecule, and the protein is further attached to the primary amino group.
- the proteins are aligned and immobilized on the substrate, and the antibody-binding protein is used as a scaffold for antibody capture.
- a polymer compound having a primary amino group in the repeating structure is bonded to an arbitrary linker molecule on the metal surface of the detection unit to form a flat polymer-modified array sensor base material,
- the primary amino groups of the polymer compound in a plurality of specific micro-regions classified in the above, it is possible to further immobilize the antibody-binding protein having a higher density and orientation control by immobilization.
- an antibody array sensor in which the effective sensitivity is further improved by immobilizing high-density antibody molecules.
- the present invention in a very small area on the array sensor substrate, it can be fixed in a uniform orientation state while maintaining its function at a high density and can be captured by the antibody binding protein having the high density and a uniform orientation.
- the antibody molecule thus obtained can also be reliably used because the binding between the protein and the pile molecule can be reliably achieved not at the site responsible for the antigen binding function of the antibody molecule but at a site called the constant region, which is not related to the binding function. It can be fixed to a specific area on the array sensor with high orientation and high density.
- the density of the immobilized antibody-binding protein can be further amplified, thereby increasing the sensitivity.
- An antibody array sensor can be provided.
- the immobilized antibody molecule enables each molecule to exhibit the maximum antigen-binding function, and As the number of molecules increases, the sensitivity deficiency of the surface plasmon resonance array sensor can be improved, and the measurement can be performed with high reproducibility.
- all the bonds are formed by stable covalent bonds on the array sensor substrate for capturing the antibody, which is composed of an array sensor metal surface linker one molecule antibody binding protein or an array sensor metal surface linker one molecule polymer compound antibody binding protein.
- a simple regenerating operation of the surface of the array sensor for desorbing the used antibody molecules by applying an appropriate acid or salt solution, etc., and binding and using new antibody molecules separately is performed. This makes it possible to provide the ability to fully contribute to the realization of an automatic measurement device using an antibody array sensor by automating a series of these operations.
- a surface structure exposing a primary amino group sufficient to adsorb negatively charged antibody-binding protein by ionic interaction is required as an array sensor substrate.
- the configuration of the substrate that satisfies this performance is to expose the primary amino groups on the metal (mainly gold) surface of the detection unit originally provided in the surface plasmon resonance array sensor on the Balta water side, and to form a covalent bond with the metal
- a linker which is a divalent low-molecular compound that can be bound by a single molecule.
- Such a linker molecule has been well studied and commercialized, but is represented by the following general formula.
- [X in the above formula (4) is thiol (HS-), disulfide (Y-A-SS-, Y, -A, -SS-), sulfide (YAS-, Y, -A, -S-), Selenol (HSe-), diselenide (Y-A-SeSe-, Y, -A, -SeSe-), selenide ( ⁇ -Se-Se-, Y, -A, -Se-) and the like.
- a spontaneous covalent bond is formed between the sulfur or selenium atom and gold.
- A is a saturated hydrocarbon chain ((CH2) n) or ethylene glycol polymer ((CH2-CH2-0-) n) (n is an integer of 2 or more), but partially unsaturated bonds (double bonds, etc.) are inserted Sometimes.
- Y is here a primary amino group.
- Y ′ may be a residue which may be a residue compatible with Y, or may be another hydrophilic group. In the latter case, it does not participate in the binding reaction.
- the linker molecule represented by the above formula (4) exhibits amphipathic property although there is a difference in strength. Therefore, in an aqueous solution in which an antibody array sensor is used, Y is directed toward the Balta water side for a plurality of times. A spontaneously formed cohesive monolayer structure on the gold surface, where the A of the child is bound. This is a structure called a self-assembly monolayer (SAM), in which the covalent bond between the sulfur atom or selenium atom and gold is further strengthened by agglomeration, and the primary amino acid used for the bond reaction. Since the group is highly oriented and exposed on the Balta water side, it is efficient as a linker molecule.
- SAM self-assembly monolayer
- the primary amino group in the polymer is bonded to the force using one linker molecule of the above formula (4).
- Various hydrophilic functional groups can be used for Y in the above formula (4).
- Y is a carboxyl group
- an active form reagent such as hydroxysuccinimide
- the polymer compound according to the present invention has a primary amino group in a repeating structure, and has a partial force other than the primary amino group, a side chain of the protein to be fixed, an ⁇ -amino group at the amino terminal, or a carboxyl group at the carboxy terminal. Any substance can be used as long as it does not react with the substance.
- Examples of the polymer compound having a primary amino group in the repeating structure include those having a polyalkylene chain, a polyamide chain, a polyester chain, a polystyrene chain, and the like, and have a repeating structure represented by the following general formula.
- X represents, for example, a monomer residue constituting a polyalkylene chain, a polyamide chain, a polyester chain, a polystyrene chain, or the like.
- the NH2 group may be a group contained in the monomer residue, or may be a group contained in the side chain of the main chain of the polymer compound.
- n indicates an integer of 2 or more.
- those having a polyalkylene chain include, for example, polyallylamine.
- This polymer compound has a high primary amine content per unit mass according to the present invention. It can be used as a thing.
- the present invention is not limited to this, and there is, for example, a copolymer of a vinyl compound having a primary amino group in a side chain and another vinyl compound! For / ⁇ , various polymer compounds such as polylysine can be used.
- any antibody-binding protein or peptide used for immobilization can be used as long as it has a binding ability to an antibody molecule.
- Staphylococcus aureus-derived Aguchi Aino A (described in A. Forsgren and J. Sjoquist, J. Immunol. (1966) 97, 822-827.), A protein G derived from Streptococus sp.Group CIG (EP013 1 142A2 (1983)) ), Protein L from pg / ⁇ ⁇ : ⁇ «:" 5, "agm ⁇ .s (described in US5 65390 (1992)), protein H from group AS e /? To" 5 ti (Described in US5 180810 (1993)), Haemophilus influenzae Kamakura's Pine (described in US6025484 (1990)), Septococcwi.
- AP4-derived protein Arp (Protein Arp 4) (described in US5210183 (1987)) Streptococcal FcRc from group C Streptococcus (described in US4900660 (1985)), protein from group A streptococcus, Type II strain (described in US5556944 (1991)), and protein from Human Colonic Mucosal Epithelial Cell (US6271362 (1994)) Description), St tapping hvhcoccus aureus, protein from strain 8325-4 (described in US6548639 (1997)), derived from Pseudomonas maltophilia Protein (described in US5245016 (1991)) and the like are known.
- proteins often have a repeating sequence
- fragmented proteins also have an ability to bind to antibody molecules.
- the protein or peptide capable of binding to the antibody molecule targeted by the present invention include these naturally occurring antibody binding proteins, partial proteins, their sequence-modified proteins, and partial proteins.
- Peptides, their mimetic peptides, artificial peptides capable of binding to antibody molecules, and the like can be mentioned.
- the general formula (6) NH-R-COOH (6)
- R is an amino acid of a protein or peptide capable of binding to an antibody molecule.
- a protein or a protein having the binding ability represented by the general formula (6) NH-R-COOH may be used.
- R 1 is an amino acid sequence of a protein or peptide capable of binding to the above-mentioned antibody molecule.
- R 2 is a linker peptide extending between the protein to be immobilized represented by the general formula (1) and the amphipathic linker molecule on the metal surface.
- amino acid sequence of 2 is arbitrary and its type and number are not limited.
- Gly-Gly-Gly-Gly or the like can be used.
- Such a fusion protein is combined with a gene encoding the protein represented by the general formula (6).
- the gene can be obtained by preparing a gene encoding a protein, expressing the gene in a host organism such as Escherichia coli, and then separating and purifying the expressed protein.
- Such a fusion protein can be obtained by a known technique (for example, M. Iwakura et al., J. Biochem. Ill. 37-45 (1992)).
- the fusion protein can be produced by a combination of a genetic engineering technique and a conventional protein synthesis technique, or by only a protein synthesis technique.
- Preferred sequences include.
- a sequence containing a large amount of aspartic acid or glutamic acid should be designed such that the isoelectric points of the substances of the above general formulas (7) and (8) are between 4 and 5.
- a suitable class of such sequences is Ararael-polyaspartic acid.
- Protein A from Staphylococcus aureus is composed of five domains named A, B, C, D, and E, which have remarkably similar amino acid sequences, and a sequence associated therewith.
- Each of these domains is composed of 57 amino acids, but each has a stable structure alone and can be expressed in large amounts in, for example, Escherichia coli.
- each domain can exert its own binding ability to an antibody molecule. Its binding strength is almost the same as that of the naturally-occurring whole protein A when two force domains that are weaker than the naturally-occurring whole protein A are joined. Therefore, focusing on the domain of protein A, we designed a sequence for immobilization of two types, a single domain (this is called a monomer) and two linked domains (this is called a dimer). did.
- SEQ ID NO: 1 is an amino acid sequence of an immobilization protein prepared for subjecting the A domain monomer of protein A to immobilization reaction.
- SEQ ID NO: 2 is an immobilization of the A domain monomer of protein A. 2 shows the amino acid sequence of a protein for immobilization prepared for use in the dani reaction.
- SEQ ID NO: 1 is an amino acid sequence of an immobilization protein prepared for subjecting the A domain monomer of protein A to immobilization reaction.
- SEQ ID NO: 2 is an immobilization of the A domain monomer of protein A. 2 shows the amino acid sequence of a protein for immobilization prepared for use in the dani reaction.
- the respective sequences are represented by the polyglycine cysteine residue and alanine residue shown in SEQ ID NO: 5 at the carboxy-terminal side of the A domain monomer sequence of protein A and the A domain dimer sequence of protein A shown in SEQ ID NOs: 3 and 4. This is a sequence obtained by adding the sequence of base-polyaspartic acid.
- SEQ ID NO: 3 is a sequence obtained by adding the sequence of base-polyaspartic acid.
- SEQ ID NO: 5 four glycine residues are shown as the sequence of a part of the linker, but the sequence of the linker is arbitrary and is not limited in length or type.
- the cysteine residue is an essential residue for converting the SH group in the side chain into a cyanocysteine and utilizing it for the immobilization reaction.
- the subsequent sequence of alanine-polyasnogic acid was a sequence introduced to promote the immobilization reaction and increase the reaction efficiency, and the isoelectric point of the protein shown in SEQ ID NOS: 1 and 2 was changed from 4 to 5. Any array can be used as long as it can be a value between them.
- the proteins shown in SEQ ID NO: 1 and SEQ ID NO: 2 can also be produced by using a chemical synthesis technique, but are obtained by expressing the gene encoding the sequence in a host such as Escherichia coli and separating and purifying from the expressing cells.
- a chemical synthesis technique but are obtained by expressing the gene encoding the sequence in a host such as Escherichia coli and separating and purifying from the expressing cells.
- SEQ ID NO: 1 Examples of the sequences encoding the proteins shown in SEQ ID NO: 1 and SEQ ID NO: 2 include the nucleotide sequences shown in SEQ ID NO: 6 and SEQ ID NO: 7, respectively.
- SEQ ID NO: 6 Examples of the sequences encoding the proteins shown in SEQ ID NO: 1 and SEQ ID NO: 2 include the nucleotide sequences shown in SEQ ID NO: 6 and SEQ ID NO: 7, respectively.
- sequences shown in SEQ ID NO: 8 and SEQ ID NO: 9 can be artificially synthesized by chemically synthesizing V and some fragments, and then using a PCR method or an enzyme such as DNA ligase.
- the synthetic gene thus obtained is inserted into an appropriate vector using a restriction enzyme site, and is expressed in a host cell.
- Any vector can be used as long as an appropriate restriction enzyme site can be used.
- pUC-type and PBR-type high copy number vectors are suitable as commercially available vectors.
- the protein which has been expressed and accumulated can be purified to homogeneity from a cell-free extract of the expressed cells by a chromatography operation usually used for protein purification.
- a chromatography operation usually used for protein purification.
- anion exchange chromatography, gel filtration chromatography, etc. are effective.
- Affinity chromatography using a carrier on which immunoglobulin is immobilized is most effective.
- the antibody binding protein for immobilization prepared as described above is arranged and adsorbed on a protein array substrate, but the method is not particularly limited. Any method can be used as long as the protein solution can be spotted on the region. For example, there is a method using a needle-like object such as a pin, an ink jet, a capillary, or the like. Any of these methods may be used. It is also possible to use a picking robot. Hereinafter, as an example, a method of spotting using a capillary will be described in detail.
- a solution of the protein for immobilization represented by the general formula (7) is filled in the capillaries, and an appropriate amount of the protein solution can be spotted at an intended place by applying a suitable pressure to the upward force. is there.
- the substrate for immobilization has a water-absorbing property
- the solution can be quickly absorbed into the substrate without applying pressure if the protein solution has a volume of about 10 ⁇ l. Will be done.
- the solvent of the protein solution diffuses in all directions around the spot, but remains at the spot because the protein is adsorbed to primary amine by electrostatic interaction. Therefore, it is possible to adsorb proteins to small regions at high density.
- proteins can be aligned and fixed in an arbitrary pattern shape. This can be performed by computer control, for example, by printing a pattern drawn on a computer with an ink jet printer. Therefore, it is obvious that any method used for alignment can be applied, and this does not limit the present invention.
- the protein array may be directly formed by adsorbing and immobilizing the spotted proteins, but at this stage, the proteins are bound to the substrate by non-covalent bonds such as electrostatic interactions. Since the bond strength is low, in order to firmly immobilize the protein, an amide bond is further formed between the carboxy group at the carboxy terminus of the protein and the primary amino group of the polymer on the substrate. . In order for this reaction to take place, the cysteine residue introduced at the carboxy terminus of the protein for immobilization was used. The sulfhydryl group of the group needs to be cyanated and converted to cyanocysteine.
- the sulfhydryl group of the cysteine residue in the protein of the general formula (7) needs to be converted to cyanocysteine by converting the sulfhydryl group to a cyanocysteine.
- the cyanated protein obtained by the conversion is a protein represented by the following general formula (9).
- R and R R are the same as R and R R in the general formula (7), respectively.
- R is a linker peptide, R is a strongly negative charge near neutrality and R
- This cyanation reaction can be performed using a commercially available cyanation reagent.
- cyanation reagent 2-nitro-5-thiocyanobenzoic acid (NTCB) (see Y.Degani, A. Ptchornik, Biochemistry, 13, 1-11 (1974)) )
- NTCB 2-nitro-5-thiocyanobenzoic acid
- Shiano-dani using NTCB can be performed efficiently in a 10 mM phosphate buffer at pH 7.0.
- the fixing reaction proceeds by making the solvent weak alkaline. That is, an amide bond is formed between the carboxyl group of the amino acid residue immediately before the cyanocysteine residue and the primary amino group of the carrier. This can be achieved, for example, by replacing the buffer with a 10 mM boric acid buffer at pH 9.5.
- the carboxy terminal side of the protein main chain is adsorbed to the primary amino group side of the polymer compound on the carrier, and the amide formation reaction binds to the primary amino group only at the carboxy terminal of the protein main chain, thereby homogenizing the protein.
- the antibody-binding protein was immobilized on the protein array substrate of the present invention and the immobilizing protein by performing the immobilization by the above-described operation.
- An antibody array sensor immobilized at a high density of about several g / mm 2 can be produced.
- an NH2-chip or COOH chip attached to Toyobo equipment, Multi SPRinter is used as a surface plasmon resonance array sensor exposing the primary amine on the surface, and this is attached to the equipment. investigated.
- Each of these chips divides the metal surface on the chip into 98 microscopic areas, each of which has an amino or carboxyl group at the end and a thiol group at the opposite end.
- Polyethylene glycol (PEG) molecules provide a single layer of stable SAM surface.
- poly-L-lysine commercially available from Sigma-Aldrich was used.
- the antibody-binding protein prepared for use in immobilization was prepared by adding the amino acid sequence of the linker-peptide portion to protein A (SEQ ID NO: 1).
- Ala-Asp-Asp-Asp-Asp-Asp-Asp-Asp-Asp) are sequentially added proteins (SEQ ID NO: 2), all of which have been prepared by the present inventor (Japanese Patent Application No. 2003-352937). Described in). Further, the antibody immobilized on the binding protein is an anti-hige IgG antibody. This antibody was derived from a heron (Funakoshi), and the reaction was observed by applying an anti-Pein 'albumin hidge antibody (Funakoshi) to the surface to which this antibody was bound.
- a mixed aqueous solution of (N-Hydroxysuccinimide) was dropped so as to cover the whole, and allowed to stand for 1 hour to activate the surface carboxylic acid.
- 100 ⁇ g / mL anti-hidge IgG antibody dissolved in HEPES buffer 0.05 M HEPES (pH 7.4) + 0.2 M NaCl
- HEPES buffer 0.05 M HEPES (pH 7.4) + 0.2 M NaCl
- a mixed aqueous solution of (N-Hydroxysuccinimide) was dropped so as to cover the whole and allowed to stand for 1 hour to activate the surface carboxylic acid.
- an aqueous solution containing 1% poly-L-lysine (molecular weight: 150,000 to 300,000) was applied to a small area of the surface plasmon resonance array sensor using a pin-type automatic spotting device manufactured by Toyobo. And kept for 2 hours by keeping the humidity at 80% in a sealed container.
- a 1.0 M ethanolamine hydrochloride aqueous solution pH 8.5 was allowed to act for 30 minutes to inactivate the unreacted carboxylic acid-activated amide.
- a polymer-modified SPR sensor chip constructed in this way was mounted on a Multi SPRinter flow cell, and a recombinant protein A molecule containing 10 g / mL of negatively charged amino acids and cysteine residues was added to the flow cell. The liquid was circulated for 1 hour to promote the binding between the protein terminal and the primary amino group in the polymer by ionic interaction.
- the surface plasmon resonance antibody array according to the present invention is obtained by circulating 10 / zg / mL anti-hidden IgG antibody and a heron-derived antibody to bind to the protein A molecule on the surface.
- the sensor was completed.
- FIG. 1 shows that a surface plasmon resonance antibody array sensor was immobilized with an anti-hidden IgG antibody and a heron-derived antibody according to the conventional method and the present invention, respectively, and a 10 g / mL anti-human albumin antibody was detected.
- FIG. 3 is a diagram in which a reaction was observed with (Funakoshi) acting. The vertical axis is the signal value of surface plasmon resonance, and the horizontal axis is time. Thick horizontal lines indicate the time during which 10 g / mL anti-serum / albumin antibody (Funakoshi) was circulated through the flow cell, and during the other times, the HEPES buffer was circulated.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
明 細 書 Specification
表面プラズモン共鳴抗体アレイセンサ作製用基板及びその作製方法 技術分野 TECHNICAL FIELD The present invention relates to a substrate for producing a surface plasmon resonance antibody array sensor and a method for producing the same.
[0001] 本発明は、表面プラズモン共鳴を原理とする抗体アレイセンサ作製用基板、それを 用いた表面プラズモン共鳴を原理とする抗体アレイセンサ、及びそれらの作製方法 に関する。 The present invention relates to a substrate for producing an antibody array sensor based on surface plasmon resonance, an antibody array sensor based on surface plasmon resonance using the same, and a method for producing them.
背景技術 Background art
[0002] 従来、平面状固体基材 (基板)の特定多数の微小領域に多種類の生体分子を固定 化し、結合相手として候補となる別の生体分子を含む溶液を接触させることにより、結 合現象の有無、その強度等を観測することで、生体分子の有する重要な機能である 分子特異的結合 (相互作用)現象を高速かつ網羅的に検定する試みがなされてきた 。この手法に利用される、数センチ四方の表面上に数百力 数万の異なる生体分子 を指定された個々の微小領域ごとに結合させて調製した平面状固体基材 (基板)をァ レイまたはチップと称している力 近年の細胞などの生命単位中に膨大かつ多種に 渡って存在し、システムを構築している生体分子群 (遺伝子群を指す場合ゲノム、タ ンパク質群を指す場合プロテオームと呼ばれる)を網羅的かつ総合的に解析し尽く すことを志向したゲノミタスあるいはプロテオミタスと呼ばれる研究手法の求める高速 かつ網羅的解析を提供できる可能性力 重要性を増している。 Conventionally, many types of biomolecules have been immobilized on a specified number of minute regions of a planar solid base material (substrate), and the solution is contacted with a solution containing another biomolecule that is a candidate for a binding partner. Attempts have been made to rapidly and comprehensively test molecule-specific binding (interaction) phenomena, an important function of biomolecules, by observing the presence or absence of phenomena, their strength, and the like. In this method, a planar solid substrate (substrate) prepared by binding hundreds of thousands of different biomolecules to specified individual microregions on a surface several centimeters square is used as an array or The power of what is referred to as a chip The biomolecules that exist in a vast and diverse manner in a living unit such as a cell in recent years and constitute a system (genome when referring to genes, proteome when referring to proteins) The possibility of providing high-speed and comprehensive analysis required by a research method called genomics or proteomics, which aims to conduct a comprehensive and comprehensive analysis of the information, is becoming increasingly important.
[0003] このようにアレイ技術は、分子結合現象の検出を平面状固体基材 (基板)の狭い領 域に高度に集積させることにより、超微量の生体分子試料を用いた解析を高速かつ 網羅的に執り行うことができる可能性を提供するが、反面、この技術に必須の検出技 術では、量的に極度に限定された分子の結合現象を高感度に検出することが求めら れてきた。実際、このアレイ技術の応用先として先行したゲノム解析においては、対 象となる接触させる遺伝子 (DNA分子)にあらカゝじめ強 、蛍光を発生させることがで きる蛍光分子を標識し、いわゆる DNAアレイ上に固定ィ匕された特定遺伝子との結合 の有無をその遺伝子が固定化された微小領域に蛍光分子の励起波長をもった高工 ネルギー型レーザによる照射を行って、生成される蛍光から判定してきた。 [0004] 生命現象の設計図にも喩えられる遺伝子を対象にしたゲノム解析が進展するにつ れて、その設計図の産物であり、動的生命現象の中枢を担うタンパク質を網羅的に 解析するプロテオーム解析が後を追うように勃興してきた。ここでも、膨大かつ多種の 生体分子を網羅的かつ総合的に解析し尽くすために、ゲノム解析で威力を発揮した アレイ技術が取り入れられて 、る。ゲノムに比べて遙かに分子種ならびにその結合現 象の多様性が膨大なプロテオームにおいては、 DNAアレイのアナロジーとして、任 意のタンパク質を平面状固体基材 (基板)上に集積固定ィ匕したタンパク質アレイも開 発されているが、さらに特定機能のタンパク質を特異的に識別して有用な分子情報 をもたらすことのできるタンパク質である抗体分子を固定ィ匕タンパク質に選定した抗 体アレイが実用的な形態として注目されており、一部上巿に至ったものも存在する。 [0003] As described above, the array technology integrates the detection of molecular bonding phenomena in a narrow area of a planar solid substrate (substrate) at a high level, thereby enabling high-speed and comprehensive analysis using an extremely small amount of biomolecule samples. It offers the possibility of performing a specific method, but on the other hand, the detection technology essential for this technology has been required to detect the binding phenomena of molecules extremely limited in quantity with high sensitivity . In fact, in genomic analysis, which is an advanced application of this array technology, a gene (DNA molecule) to be contacted is labeled with a fluorescent molecule capable of generating fluorescence. The presence or absence of binding to a specific gene immobilized on the DNA array is determined by irradiating the microregion where the gene is immobilized with a high-energy laser with the excitation wavelength of the fluorescent molecule to generate fluorescent light. Has been determined. [0004] With the progress of genome analysis of genes that can be compared to blueprints of life phenomena, comprehensive analysis of proteins that are the products of the blueprints and play a central role in dynamic life phenomena is performed. Proteome analysis has rushed to follow. Here, too, an array technology that has demonstrated its power in genomic analysis has been adopted in order to exhaustively and comprehensively analyze a vast and diverse variety of biomolecules. In a proteome in which the diversity of molecular species and their binding phenomena is far greater than that of the genome, as an analogy to DNA arrays, arbitrary proteins are integrated and immobilized on a planar solid substrate (substrate). Although protein arrays have been developed, it is practical to use antibody arrays in which antibody molecules that can specifically identify proteins with specific functions and provide useful molecular information are selected as immobilized proteins. Attention has been paid to these forms, and some of them have been improved.
[0005] しかしながら、 DNAアレイのアナロジーから展開したタンパク質アレイあるいは抗体 アレイには、 DNAアレイには生じな力つた新たな問題点が生じる。すなわち、 1)タン ノ ク質の結合反応は DNAのそれに比べ比較的弱いものも多いため、検出表面の単 位面積あたりに結合する量は少なくなる、 2)基本的に直鎖状分子のまま結合を行う DNAでは、結合に寄与する鎖中央部を避けて分子末端を利用して蛍光分子標識あ るいは表面への固定ィ匕を行えば、それらの結合現象への妨害は無視できるが、直鎖 状高分子が 3次元的に立体構造をつくるタンパク質では、タンパク質中での標識部 位あるいは固定ィ匕部位がまちまちとなるため、タンパク質結合機能に必須の部位と重 複する場合も多ぐ結合させた蛍光分子や固定化のための分子結合部位が結合現 象そのものを著しく阻害することがある。これらの結果、タンパク質アレイあるいは抗 体アレイでは、実効上有効な感度が得られない、あるいは有効な検出可能範囲の下 限で測定するために再現性がな 、などの測定に深刻な問題が生じ、これ力 ¾NAァ レイに比して普及が進まない要因となってきた。 [0005] However, a protein array or an antibody array developed from the analogy of a DNA array has a new powerful problem that does not occur in a DNA array. That is, 1) the binding reaction of proteins is relatively weak compared to that of DNA, so the amount bound per unit area of the detection surface is reduced.2) Basically, linear molecules remain In the DNA to be bound, the interference with the binding phenomenon can be neglected if the fluorescent molecule labeling or immobilization on the surface is performed using the molecular ends avoiding the center of the chain contributing to the binding, For proteins whose linear macromolecules form a three-dimensional structure, the labeling site or immobilization site in the protein varies, and often overlaps with the site essential for protein binding function. Bound fluorescent molecules or molecular binding sites for immobilization can significantly inhibit the binding phenomena themselves. As a result, serious problems arise in the measurement of protein arrays or antibody arrays, in which effective sensitivity is not practically obtained, or measurement is performed at the lower end of the effective detectable range, resulting in lack of reproducibility. However, this has become a factor that has not spread as much as NA arrays.
[0006] このような問題を克服するために近年、アレイセンサの開発が進められてきた。これ はアレイを構成するための平面状固体基材 (基板)そのものをセンサの検出部分とす ることで、上記 2)の問題のうち特に蛍光分子標識の使用を無用とするもので、非標識 分子の検出を分子の質量に基づいて行える表面プラズモン共鳴センサを利用したも のが実用化されている。表面プラズモン共鳴センサは、平板上ガラスに金属 (主に金) の薄膜を蒸着させたものにガラス側力 可視光線を全反射させ、その際にガラスと金 属の界面に染みだしたエバネッセント波と呼ばれる量子波の波数 (振動数)と金属側 に接する媒質の表面プラズモン波の波数が一致すると表面プラズモン共鳴と呼ばれ るエネルギーの吸収が起き、反射光が減光する原理を応用したもので、金属側表面 での分子レベルでの物質の吸着 ·解離現象に伴う屈折率変化が減光を生じる共鳴 角を変化させるためにその角度を測定することで表面上の質量変化をモニターする ことができるセンサである。表面プラズモン共鳴型センサの場合、この金属表面を多 数の区分された特定領域に分割して使用することが可能であるので、個々の特定領 域に分子を固定ィ匕することでアレイセンサとしての機能を発揮させることができる。 [0006] In order to overcome such a problem, in recent years, the development of array sensors has been promoted. This uses the flat solid substrate (substrate) itself to constitute the array as the detection part of the sensor, and eliminates the use of fluorescent molecule labels, among the problems in 2) above. A sensor using a surface plasmon resonance sensor that can detect a molecule based on the mass of the molecule has been put to practical use. Surface plasmon resonance sensor is made of metal (mainly gold) The glass-side force on a thin film of a thin film deposited on the glass, the visible light is totally reflected, and at that time, the wave number (frequency) of the quantum wave called the evanescent wave that seeps into the interface between glass and metal and the medium in contact with the metal When the wave numbers of surface plasmon waves coincide, energy absorption called surface plasmon resonance occurs and the reflected light diminishes.This is based on the adsorption and dissociation phenomena of substances at the molecular level on the metal side surface. It is a sensor that can monitor the change in mass on the surface by measuring the resonance angle at which the change in the refractive index causes dimming. In the case of a surface plasmon resonance type sensor, it is possible to use this metal surface by dividing it into a large number of divided specific regions, and by immobilizing molecules in each specific region, an array sensor is obtained. Function can be exhibited.
[0007] 原理力も明らかなように、このアレイセンサでは非標識の分子を測定できるため、蛍 光分子による標識は不要となるが、反面蛍光標識法による検出法よりも原理的に感 度の劣る表面プラズモン共鳴法を採用したために、抜本的な実効感度の向上は達 成できていない。 [0007] As can be seen from the principle power, this array sensor can measure unlabeled molecules, so that labeling with fluorescent molecules is not necessary, but sensitivity is in principle lower than that of the detection method using fluorescent labeling. The adoption of the surface plasmon resonance method has not achieved a drastic improvement in effective sensitivity.
そこで、本発明はこれまでのアレイセンサ、特に実用上有用な抗体アレイセンサに おける上記問題 1)の単位面積あたりの結合量の向上、ならびに上記問題 2)のタン ノ^質の固定ィ匕における結合機能阻害の克服に関して抜本的解決を与えることを目 的としている。 Accordingly, the present invention relates to the improvement of the amount of binding per unit area of the above problem 1) in the conventional array sensor, particularly the practically useful antibody array sensor, and the improvement of the protein immobilization in the above problem 2). The aim is to provide a radical solution for overcoming binding function inhibition.
発明の開示 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0008] 本発明は、抗体アレイセンサの作成において、抗体分子固定ィ匕手段としてタンパク 質主鎖のカルボキシ末端の一箇所で平面状基材表面へ配向制御固定ィヒした抗体 結合性タンパク質を介して結合させる手段を採用して固定化された抗体分子の結合 機能に構造的阻害を与えないようにする手段を提供するとともに、これをさらに発展 せしめ、単位面積あたりの固定ィ匕量を増大させ、アレイ基材上の小さな領域に、高密 度でタンパク質を固定ィ匕でき、かつ、これにより基板上のタンパク質の固定領域数を 増大させる手段を開発することを課題とするものであり、このことにより、例えば、抗体 アレイセンサにおける検出分子系の規格化、検出感度の増大等を通じて抗体アレイ の実用性の向上ならびに利用分野の拡大を可能とするものである。 課題を解決するための手段 [0008] The present invention provides an antibody array sensor, in which an antibody-binding protein is used as an antibody molecule immobilizing means, the orientation of which is immobilized on a planar substrate surface at one carboxy terminus of a protein main chain. Means to prevent structural inhibition of the binding function of the immobilized antibody molecule by employing means for binding, and further develop this to increase the amount of immobilization per unit area. It is an object of the present invention to develop a means for immobilizing a protein with high density on a small area on an array substrate and thereby increasing the number of immobilized areas of the protein on the substrate. As a result, for example, it is possible to improve the practicality of antibody arrays and to expand the field of application through standardization of detection molecular systems in antibody array sensors, increase in detection sensitivity, etc. Than it is. Means for solving the problem
[0009] 本発明者等は上記課題を解決するため、まずアレイセンサに用いる検出部を兼ね た平面状基材上の個々の微小領域表面に、シァノシスティン残基を介したアミド結合 形成反応を利用しタンパク質主鎖のカルボキシ末端のカルボキシル基を介して整然 と並べて固定ィ匕した抗体認識タンパク質を抗体分子固定ィ匕のための足場として用い ることを想起し、同一の抗体認識分子を配向を揃えて結合させて各微小領域間での 抗体認識分子の固定化量偏差を解消することにより、抗体認識分子に結合させて 2 次的に固定化する抗体分子の固定化量を、各微小領域間で規格化できることを見 出した。 In order to solve the above-mentioned problems, the present inventors firstly formed an amide bond formation reaction via a cyanocysteine residue on the surface of each minute region on a planar substrate also serving as a detection unit used in an array sensor. Using the antibody recognition protein, which has been ordered and immobilized via the carboxyl group at the carboxy terminus of the protein backbone, using as a scaffold for immobilization of the antibody molecule, and aligning the same antibody recognition molecule. To eliminate the deviation of the amount of immobilized antibody recognition molecules between each microregion, thereby reducing the amount of immobilized antibody molecules that are secondarily immobilized by binding to the antibody recognition molecules. We have found that it can be standardized between domains.
[0010] さらに、単位面積当たりの固定ィ匕量 (すなわち、抗体の固定化密度)を、単分子吸 着レベルの 100から 1000倍(すなわち数/ z g/mm2程度)に高めることを目的に鋭意研 究を行った結果、一級アミノ基を繰返し構造中に有するポリマー化合物を平面状基 材表面に導入し、導入したポリマー化合物の一級アミノ基に、抗体認識タンパク質主 鎖のカルボキシル末端を結合させることにより、検出部である平面状基材にタンパク 質を整然と並べながら、極めて高密度に固定ィ匕できることを見出し、しかるに高密度 化の恩恵によってこれまで抗体アレイ検出系としては感度的に利用の困難であった 非標識型センサである表面プラズモン共鳴センサの検出部に応用でき、なおかつポ リマーおよび抗体認識分子の固定ィ匕が強固な共有結合により達成できる利点を利用 して酸あるいは塩溶液等を用いた抗体分子のアレイセンサ表面への可逆的な脱着 が可能となり、もって繰り返しセンサ表面の再生処理を可能にできることから、多量被 検試料に対して各種抗体分子を用いた計測を繰り返し自動的に行えるセンサを基軸 とした完全自動測定システムへの応用^ |lj案し、本発明を完成させるに至ったもので ある。 [0010] Furthermore, with the aim of increasing the amount of immobilization per unit area (ie, the immobilization density of the antibody) to 100 to 1000 times the level of single molecule adsorption (ie, about several / zg / mm 2 ). As a result of intensive research, a polymer compound having a primary amino group in a repeating structure is introduced on the surface of the planar substrate, and the carboxyl terminus of the antibody-recognition protein main chain is bonded to the primary amino group of the introduced polymer compound. As a result, it has been found that proteins can be immobilized at extremely high density while orderly arranging proteins on a planar base material as a detection unit. It can be applied to the detection part of surface plasmon resonance sensor, which is an unlabeled sensor, which has been difficult, and the immobilization of polymers and antibody recognition molecules is achieved by strong covalent bonds. Utilizing the advantages that can be achieved, it is possible to reversibly desorb antibody molecules to the array sensor surface using an acid or salt solution, etc., thereby enabling repeated regeneration of the sensor surface. The present invention was completed by developing an application to a fully automatic measurement system based on a sensor that can automatically and repeatedly perform measurement using various antibody molecules ^ | lj, and completed the present invention.
[0011] すなわち、本発明は、以下の(1)一(11)に示されるとおりである。 That is, the present invention is as described in the following (1)-(11).
( 1)検出部表面上の特定領域に抗体結合性タンパク質あるいはペプチドを整列固定 ィ匕させたことを特徴とする表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板。 (1) An array substrate for producing a surface plasmon resonance antibody array sensor, wherein an antibody-binding protein or peptide is aligned and fixed in a specific region on the surface of a detection section.
(2)検出部表面上の特定領域に抗体結合性タンパク質あるいはペプチド整列固定 ィ匕させた基板を用いて、抗体タンパク質を整列固定化させたことを特徴とする表面プ ラズモン共鳴抗体アレイセンサ。 (2) A surface plate characterized in that antibody proteins are aligned and immobilized on a substrate on which antibody-binding proteins or peptides are aligned and immobilized in a specific region on the detection surface. Rasmon resonance antibody array sensor.
(3)抗体結合性タンパク質ある 、はペプチドのカルボキシ末端をリンカ一配列を介し て、一級アミノ基を有するセンサ検出部上のリンカ一分子とアミド結合で固定ィ匕するこ とにより得られ、一般式(1) (3) An antibody-binding protein is obtained by immobilizing the carboxy terminus of a peptide via a linker sequence with a linker molecule on a sensor detection unit having a primary amino group with an amide bond, and Equation (1)
NH— Rト CO— NH— R— CO— NH— Y— Z (1) NH— R to CO— NH— R— CO— NH— Y— Z (1)
2 2 twenty two
で表されることを特徴とする表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板 An array substrate for producing a surface plasmon resonance antibody array sensor, characterized by being represented by:
[上記式中、 Rは、抗体結合性タンパク質もしくはペプチドのアミノ酸配列、 Rは任意 [Wherein, R is the amino acid sequence of the antibody-binding protein or peptide, and R is any
1 2 のリンカ一配列のアミノ酸配列、 Yはリンカ一分子、 zはセンサ検出部表面基材を表す Amino acid sequence of linker sequence of 1 2, Y represents linker molecule, z represents surface material of sensor detector
] ]
(4)上記(3)記載の一級アミノ基を有するリンカ一分子が、 (4) a linker molecule having a primary amino group according to the above (3),
一般式 (2) General formula (2)
(NH -X)n (2) (NH-X) n (2)
2 2
で示される一級アミノ基を有するポリマー化合物を含む分子である(但し、式中 Xは、 ポリマー化合物の繰り返し単位の一級アミノ基以外の残基を表し、 nは 2以上の整数 を表す。 )ことを特徴とする表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板。(Wherein, X represents a residue other than the primary amino group of the repeating unit of the polymer compound, and n represents an integer of 2 or more). An array substrate for producing a surface plasmon resonance antibody array sensor, comprising:
(5)上記 (4)の一般式(2)で表されるポリマー化合物が、ポリアリルァミンであることを 特徴とする表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板 (5) An array substrate for producing a surface plasmon resonance antibody array sensor, wherein the polymer compound represented by the general formula (2) in the above (4) is polyallylamine.
(6)上記 (4)の一般式(2)で表されるポリマー化合物が、ポリリジンであることを特徴と する表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板。 (6) An array substrate for producing a surface plasmon resonance antibody array sensor, wherein the polymer compound represented by the general formula (2) in the above (4) is polylysine.
(7)一級アミノ基を有する検出部表面上の特定領域に、一般式 (3) (7) In a specific region on the detection section surface having a primary amino group, a general formula (3)
NH 一 R -C00H (3) NH-I R-C00H (3)
2 1 twenty one
〔式中、 Rはタンパク質もしくはペプチドのアミノ酸配列を表す。〕 [Wherein, R represents an amino acid sequence of a protein or peptide. ]
で示される抗体結合性タンパク質もしくはペプチドを整列固定ィ匕した上記(1)記載の 表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板を作成する方法であって、 一級アミノ基を有する基材上に整列配置、吸着された、一般式 (4) The method for producing an array substrate for producing a surface plasmon resonance antibody array sensor according to the above (1), wherein the antibody-binding protein or peptide is aligned and immobilized, the array being arranged on a substrate having a primary amino group. , Adsorbed, general formula (4)
NH 一 R - CO— NH— CH(CH - SCN)— CO— NH— R - COOH NH-R-CO-NH-CH (CH-SCN)-CO-NH-R-COOH
2 2 … ·(4) 2 2… · (4)
2 1 twenty one
〔式中、 Rは抗体結合性タンパク質もしくはペプチドのアミノ酸配列を表し、 Rは中性 付近で強く負に荷電しかつ一般式 (3)で表されるタンパク質もしくはペプチドの等電 点を酸性にし得るアミノ酸配列を表す。〕 [Wherein, R represents the amino acid sequence of the antibody-binding protein or peptide; It represents an amino acid sequence that is strongly negatively charged in the vicinity and can make the isoelectric point of the protein or peptide represented by the general formula (3) acidic. ]
で示されるタンパク質もしくはペプチドと、該センサ上のリンカ一分子の一級アミノ基 に、一般式(3)のタンパク質主鎖のカルボキシ末端をペプチド結合させたうえで、該 抗体結合性タンパク質もしくはペプチドにより抗体分子を結合させてなることを特徴と する表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板の作成方法。 A peptide or a carboxy terminus of the protein main chain of the general formula (3) is bonded to a protein or peptide represented by the formula below and a primary amino group of a linker molecule on the sensor, and then the antibody is bound by the antibody-binding protein or peptide. A method for producing an array substrate for producing a surface plasmon resonance antibody array sensor, comprising binding molecules.
(8)上記(7)の一級アミノ基を有するリンカ一分子が、一般式 (2)で示される一級アミ ノ基を有するポリマー化合物を含む分子であることを特徴とする表面プラズモン共鳴 抗体アレイセンサ作製用アレイ基板。 (8) A surface plasmon resonance antibody array sensor, wherein the linker molecule having a primary amino group (7) is a molecule containing a polymer compound having a primary amino group represented by the general formula (2): Array substrate for fabrication.
(9)一般式(2)で表されるポリマー化合物力 ポリアリルァミンであることを特徴とする 表面プラズモン共鳴抗体アレイセンサ作製用アレイ基板の作製方法。 (9) A method for producing an array substrate for producing a surface plasmon resonance antibody array sensor, wherein the polymer compound represented by the general formula (2) is polyallylamine.
(10)—般式(2)で表されるポリマー化合物力 ポリリジンであることを特徴とする表面 プラズモン共鳴抗体アレイセンサ作製用アレイ基板の作製方法。 (10) A method for producing an array substrate for producing a surface plasmon resonance antibody array sensor, characterized in that the polymer compound represented by the general formula (2) is polylysine.
(11)酸'アルカリ '塩溶液等を用いた抗体分子の脱着再生操作を施すことにより繰り 返し同質の測定を可能としたことを特徴とする上記(2)記載の表面プラズモン共鳴抗 体アレイセンサを用いた抗原分子の測定方法。 (11) The surface plasmon resonance antibody array sensor as described in (2) above, wherein the same quality can be repeatedly measured by performing a desorption / regeneration operation of the antibody molecule using an acid 'alkali' salt solution or the like. A method for measuring an antigen molecule using the method.
(12)上記(2)記載の表面センサを検出部に用いること、ならびに上記(11)項記載 の繰り返し再生操作を適用することを特徴とし、試料測定回ごとに検出部表面の自動 的再生処理を行う自動送液装置、および検出により生成される測定データの自動的 収集ならびにデータ処理を可能にするデータ処理装置を一体として備えた表面ブラ ズモン共鳴抗体アレイセンサの自動測定システム。 (12) A feature of using the surface sensor described in (2) above for the detection unit and applying the repetitive reproduction operation described in (11) above, and automatically regenerating the surface of the detection unit every time the sample is measured. An automatic measurement system for a surface plasmon resonance antibody array sensor, which is equipped with an automatic liquid feeding device that performs the measurement and a data processing device that enables automatic collection and data processing of measurement data generated by detection.
発明の効果 The invention's effect
本発明によれば、表面プラズモン共鳴装置に用いる、金属等のアレイ基板表面に、 抗体分子が高密度で、かつ抗体タンパク質が配向制御されて固定化された抗体ァレ ィセンサが提供できる。表面プラズモン共鳴センサの検出部に本発明の抗体アレイ センサを使用すれば,従来の抗体アレイと比較して、実効感度が極めて顕著に増大 し、抗体アレイセンサの実用性の向上、その利用分野の拡大等が図れる。 According to the present invention, it is possible to provide an antibody array sensor in which antibody molecules have a high density and antibody proteins are immobilized in a controlled orientation on the surface of an array substrate such as a metal used for a surface plasmon resonance apparatus. If the antibody array sensor of the present invention is used in the detection section of the surface plasmon resonance sensor, the effective sensitivity is extremely remarkably increased as compared with the conventional antibody array, and the practicality of the antibody array sensor is improved. Enlargement can be achieved.
発明を実施するための最良の形態 [0013] 以下、本発明を詳細に説明する。 BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
本発明は、非標識分子検出が可能な表面プラズモン共鳴アレイセンサの検出部金 属表面のリンカ一分子の一級アミノ基に抗体結合性タンパク質を吸着させ、また、さら に該一級アミノ基に該タンパク質主鎖のカルボキシ末端を、シァノシスティン残基を 介したアミド結合形成反応を利用して結合させることにより、該基材上に該タンパク質 を整列固定化して、抗体結合性タンパク質を抗体捕捉用足場分子とした抗体捕捉用 アレイセンサ基材を調製したのち、複数かつ任意の抗体分子を該基材上のそれぞれ の特定微小領域に配された抗体結合性タンパク質により捕捉させ、抗体アレイセンサ を構築するものである。 According to the present invention, an antibody-binding protein is adsorbed to a primary amino group of a linker molecule on the surface of a detection metal of a surface plasmon resonance array sensor capable of detecting an unlabeled molecule, and the protein is further attached to the primary amino group. By binding the carboxy terminus of the main chain using an amide bond formation reaction via a cyanocystein residue, the proteins are aligned and immobilized on the substrate, and the antibody-binding protein is used as a scaffold for antibody capture. After preparing an array sensor substrate for antibody capture as a molecule, a plurality of arbitrary antibody molecules are captured by antibody-binding proteins arranged in specific small regions on the substrate, thereby constructing an antibody array sensor. Things.
[0014] さらに、一級アミノ基を繰り返し構造中に有するポリマー化合物を検出部金属表面 の任意のリンカ一分子に結合させることにより、平板状のポリマー修飾アレイセンサ基 材を作成し、該基材上において区分された複数の特定微小領域において、該ポリマ 一化合物の一級アミノ基を利用して、さらに高密度な配向制御された抗体結合タン ノ^質の固定ィ匕を可能にすることにより、より高密度な抗体分子の固定ィ匕による実効 感度のさらに向上した抗体アレイセンサを提供する。 [0014] Further, a polymer compound having a primary amino group in the repeating structure is bonded to an arbitrary linker molecule on the metal surface of the detection unit to form a flat polymer-modified array sensor base material, By using the primary amino groups of the polymer compound in a plurality of specific micro-regions classified in the above, it is possible to further immobilize the antibody-binding protein having a higher density and orientation control by immobilization. Provided is an antibody array sensor in which the effective sensitivity is further improved by immobilizing high-density antibody molecules.
本発明においては、アレイセンサ基材上の極めて小さな領域において、高密度か つその機能を保持したまま均一な配向状態で固定ィ匕でき、しかるにその高密度かつ 均一配向した抗体結合性タンパク質により捕捉された抗体分子もまた、該蛋白質-杭 体分子間の結合が、抗体分子の抗原結合機能を司る部位ではなく定常領域と呼ば れる結合機能とは無関係の部位にて確実に達成できることから、均一な配向をもって 高密度にアレイセンサ上の特定領域に固定ィ匕できる。 In the present invention, in a very small area on the array sensor substrate, it can be fixed in a uniform orientation state while maintaining its function at a high density and can be captured by the antibody binding protein having the high density and a uniform orientation. The antibody molecule thus obtained can also be reliably used because the binding between the protein and the pile molecule can be reliably achieved not at the site responsible for the antigen binding function of the antibody molecule but at a site called the constant region, which is not related to the binding function. It can be fixed to a specific area on the array sensor with high orientation and high density.
[0015] また、上記ポリマー化合物の使用によって基材表面の一級アミノ基の密度を増大さ せることにより、固定ィ匕抗体結合性タンパク質の密度をさらに増幅させることもでき、も つてより高感度な抗体アレイセンサを提供できる。 [0015] In addition, by increasing the density of primary amino groups on the surface of the base material by using the above-mentioned polymer compound, the density of the immobilized antibody-binding protein can be further amplified, thereby increasing the sensitivity. An antibody array sensor can be provided.
すなわち、このような高度に均一な配向と高い密度を同時に達成できる本発明によ り、固定化された抗体分子は個々の分子が最大限に抗原結合機能を発揮することが でき、単位面積あたりの分子数が増大するため、表面プラズモン共鳴アレイセンサで の感度不足が改善し、かつ再現性の高!、測定が可能となる。 また、アレイセンサ金属表面 リンカ一分子 抗体結合蛋白質、あるいはアレイセン サ金属表面 リンカ一分子 ポリマー化合物 抗体結合蛋白質カゝらなる抗体捕捉用 アレイセンサ基材では、すべてその結合が安定な共有結合にて形成されており、適 切な酸あるいは塩溶液等を作用させることなどで、使用した抗体分子を脱着させ、別 途新たな抗体分子を結合させて供用するためのアレイセンサ表面の簡便な再生操 作が可能となり、これら一連の操作を自動化することによる抗体アレイセンサを用いた 自動測定装置の実現に十分資することのできる能力を提供できる。 That is, according to the present invention which can achieve such highly uniform orientation and high density at the same time, the immobilized antibody molecule enables each molecule to exhibit the maximum antigen-binding function, and As the number of molecules increases, the sensitivity deficiency of the surface plasmon resonance array sensor can be improved, and the measurement can be performed with high reproducibility. In addition, all the bonds are formed by stable covalent bonds on the array sensor substrate for capturing the antibody, which is composed of an array sensor metal surface linker one molecule antibody binding protein or an array sensor metal surface linker one molecule polymer compound antibody binding protein A simple regenerating operation of the surface of the array sensor for desorbing the used antibody molecules by applying an appropriate acid or salt solution, etc., and binding and using new antibody molecules separately is performed. This makes it possible to provide the ability to fully contribute to the realization of an automatic measurement device using an antibody array sensor by automating a series of these operations.
[0016] 以下に、アレイセンサの検出部金属表面の一級アミノ基を有するリンカ一分子に直 接、あるいは、検出部金属表面の任意のリンカ一分子に結合させたポリマー化合物 の該一級アミノ基に、抗体結合性タンパク質をペプチド結合により結合させることによ り、抗体結合性タンパク質アレイ基材を作製し、さらに任意の対象となる抗体分子を 結合させることにより、表面プラズモン共鳴抗体アレイセンサを作製する手段ならび にそれを利用した測定方法について詳細に説明する。 [0016] Hereinafter, the primary amino group of a polymer compound directly bonded to a linker molecule having a primary amino group on the metal surface of the detection portion of the array sensor or bonded to an arbitrary linker molecule on the metal surface of the detection portion will be described. Then, an antibody-binding protein array substrate is prepared by binding the antibody-binding protein by peptide bond, and a surface plasmon resonance antibody array sensor is prepared by further binding any target antibody molecule. The means and the measurement method using it are described in detail.
[0017] 1.アレイセンサ基材 [0017] 1. Array sensor substrate
本発明の上記課題を達成するためには、まずアレイセンサ基材として、負に帯電し た抗体結合タンパク質をイオン相互作用により吸着できるに十分な一級アミノ基を露 出した表面構造が要求される。この性能を満たす基材の構成としては、表面ブラズモ ン共鳴アレイセンサが元来備える検出部の金属 (主に金)表面の上に一級アミノ基を バルタ水側に露出し、かつ金属とも共有結合で結合できる二価性の低分子化合物で あるリンカ一分子の介在が望ましい。このようなリンカ一分子は既によく研究され、ま た市販化もされているが、以下の一般式で示される。 In order to achieve the above object of the present invention, first, a surface structure exposing a primary amino group sufficient to adsorb negatively charged antibody-binding protein by ionic interaction is required as an array sensor substrate. . The configuration of the substrate that satisfies this performance is to expose the primary amino groups on the metal (mainly gold) surface of the detection unit originally provided in the surface plasmon resonance array sensor on the Balta water side, and to form a covalent bond with the metal It is desirable to interpose a linker, which is a divalent low-molecular compound that can be bound by a single molecule. Such a linker molecule has been well studied and commercialized, but is represented by the following general formula.
X-A-Y (4) X-A-Y (4)
[上式(4)中の Xはチオール (HS -)、ジスルフイド (Y- A- SS- ,Y,- A,- SS -)、スルフイド (Y-A-S-, Y,- A,- S -)、セレノール (HSe -)、ジセレナイド (Y- A- SeSe- ,Y,- A,- SeSe -)、 セレナイド (Υ-Α-Se-, Y,-A,-Se-)等があげられ、これらの例では硫黄原子あるいは セレン原子と金との間で自発的共有結合が形成される。 Aは飽和炭化水素鎖 ((CH2)n)やエチレングリコール重合体 ((CH2-CH2-0-)n)を表す (nはそれぞれ 2以上 の整数)が、部分的に不飽和結合 (2重結合等)が挿入されることがある。 Yはここでは 一級アミノ基である。なお、 Y'は Yに適合する残基である場合もある力 それ以外の 親水基でもよい。後者の場合、結合反応には関与しない。 ] [X in the above formula (4) is thiol (HS-), disulfide (Y-A-SS-, Y, -A, -SS-), sulfide (YAS-, Y, -A, -S-), Selenol (HSe-), diselenide (Y-A-SeSe-, Y, -A, -SeSe-), selenide (Υ-Se-Se-, Y, -A, -Se-) and the like. In the example, a spontaneous covalent bond is formed between the sulfur or selenium atom and gold. A is a saturated hydrocarbon chain ((CH2) n) or ethylene glycol polymer ((CH2-CH2-0-) n) (n is an integer of 2 or more), but partially unsaturated bonds (double bonds, etc.) are inserted Sometimes. Y is here a primary amino group. In addition, Y ′ may be a residue which may be a residue compatible with Y, or may be another hydrophilic group. In the latter case, it does not participate in the binding reaction. ]
[0018] 上式 (4)で示されるリンカ一分子は強弱の差はあるものの両親媒性を示すため、抗 体アレイセンサが用いられるような水溶液系においては Yをバルタ水側に向け複数分 子の Aが束ねられるような凝集単膜構造を金表面において自発的に形成する。これ は自己集合膜 (Self- assembly Monolayer; SAM)と呼ばれる構造で、硫黄原子あるい はセレン原子と金との間との共有結合がさらに凝集によって強化されており、結合反 応に供する一級アミノ基は高度に配向してバルタ水側に露出しているためにリンカ一 分子として効率がよい。 [0018] The linker molecule represented by the above formula (4) exhibits amphipathic property although there is a difference in strength. Therefore, in an aqueous solution in which an antibody array sensor is used, Y is directed toward the Balta water side for a plurality of times. A spontaneously formed cohesive monolayer structure on the gold surface, where the A of the child is bound. This is a structure called a self-assembly monolayer (SAM), in which the covalent bond between the sulfur atom or selenium atom and gold is further strengthened by agglomeration, and the primary amino acid used for the bond reaction. Since the group is highly oriented and exposed on the Balta water side, it is efficient as a linker molecule.
[0019] また、本発明でポリマー化合物を用いてさらに固定ィ匕量を増大させたい場合には、 上式 (4)のリンカ一分子を用いる力 これにポリマー中の一級アミノ基を結合させるた め上式 (4)中の Yには様々な親水性官能基が利用可能である。例えば、 Yがカルボ キシル基の場合、同カルボキシ基をあらかじめヒドロキシスクシンイミドのような活性ィ匕 試薬で活性ィ匕体に変換しておけばポリマー中の一級アミノ基と接触させるだけで反 応が進行するし、 Yがー級ァミノ基となる場合には同じ構造同士である力 ダルタルァ ルデヒドによる活性ィ匕を行えば反応可能であるし、その他水酸基等もェピクロロヒドリ ンゃ臭化シアンによる活性ィ匕を通じて利用できる。 Further, in the present invention, when it is desired to further increase the amount of immobilization by using a polymer compound, the primary amino group in the polymer is bonded to the force using one linker molecule of the above formula (4). Various hydrophilic functional groups can be used for Y in the above formula (4). For example, when Y is a carboxyl group, if the carboxy group is previously converted to an activated form using an active form reagent such as hydroxysuccinimide, the reaction proceeds only by contact with the primary amino group in the polymer. In the case where Y is a -amino group, it is possible to react by performing activation with dartaldehyde, which is the same structure, and other hydroxyl groups and the like can be reacted through activation with epichlorohydrin and cyanogen bromide. Available.
[0020] 本発明におけるポリマー化合物としては、一級アミノ基を繰返し構造中に有し、一 級ァミノ基以外の部分力 固定するタンパク質の側鎖もしくはァミノ末端の α—ァミノ 基もしくはカルボキシ末端のカルボキシル基と反応性の無 、ものであればどのような ものでも用いることができる。 [0020] The polymer compound according to the present invention has a primary amino group in a repeating structure, and has a partial force other than the primary amino group, a side chain of the protein to be fixed, an α-amino group at the amino terminal, or a carboxyl group at the carboxy terminal. Any substance can be used as long as it does not react with the substance.
一級アミノ基を繰返し構造中に有するポリマー化合物としては、例えば、ポリアルキ レン鎖、ポリアミド鎖、ポリエステル鎖、ポリスチレン鎖等を有するもの等が挙げられ、 以下の一般式で表される繰り返し構造を有する。 Examples of the polymer compound having a primary amino group in the repeating structure include those having a polyalkylene chain, a polyamide chain, a polyester chain, a polystyrene chain, and the like, and have a repeating structure represented by the following general formula.
(Χ-ΝΗ )η (5) 〔上記式 (5)中、 Xは、例えば、ポリアルキレン鎖、ポリアミド鎖、ポリエステル鎖、ポ リスチレン鎖等を構成するモノマー残基を表す。また、 NH2基は、該モノマー残基中 に含まれる基であってもよいし、これらポリマー化合物の主鎖力 分枝した側鎖中に 含まれる基であってもよい。 nは 2以上の整数を指す。〕 (Χ-ΝΗ) η (5) [In the above formula (5), X represents, for example, a monomer residue constituting a polyalkylene chain, a polyamide chain, a polyester chain, a polystyrene chain, or the like. Further, the NH2 group may be a group contained in the monomer residue, or may be a group contained in the side chain of the main chain of the polymer compound. n indicates an integer of 2 or more. ]
[0021] 本発明においては、これらのポリマー化合物のうち、ポリアルキレン鎖を有するもの として、例えば、ポリアリルアミンを挙げることができる力 このポリマー化合物は単位 質量当たりの一級アミン含量が高ぐ本発明におレ、て好まし 、ものとして用いることが できる。また、本発明はこれに限定されず、例えば、一級アミノ基を側鎖に有するビ- ル化合物と他のビニル化合物との共重合体、ある!/ヽはポリリジンなど各種のポリマー 化合物などが利用できる。 In the present invention, among these polymer compounds, those having a polyalkylene chain include, for example, polyallylamine. This polymer compound has a high primary amine content per unit mass according to the present invention. It can be used as a thing. The present invention is not limited to this, and there is, for example, a copolymer of a vinyl compound having a primary amino group in a side chain and another vinyl compound! For / ヽ, various polymer compounds such as polylysine can be used.
[0022] 2.抗体分子に結合能を有するタンパク質 [0022] 2. Protein capable of binding to an antibody molecule
本発明において固定ィ匕に供される抗体結合性タンパク質もしくはペプチドとしては 、抗体分子に対して結合能を有するものであれば何でも用いることができる。 In the present invention, any antibody-binding protein or peptide used for immobilization can be used as long as it has a binding ability to an antibody molecule.
抗体分子に結合能を有するタンパク質としては、 As a protein capable of binding to an antibody molecule,
Staphylococcus aureus由 のフ口アイノ A(A. Forsgren and J. Sjoquist, J. Immunol. ( 1966) 97, 822-827.に記載)、 Streptococus sp. Group CIG由来のプロテイン G (EP013 1 142A2 ( 1983) に記載)、 eptoi'ひ ΐρ/ο<:ο«:"5 ,"agm<.s由来のプロテイン L (US5 65390 ( 1992) に記載) 、 group A S e/?to "5 ti来のプロテイン H (US5 180810 ( 1993) に記載) 、 Haemophilus influenzae巾来のプ Ό亍イン Ό (US6025484 ( 1990) に記載) 、 S eptococcwi. AP4由来のプロテイン Arp (Protein Arp 4) ( US5210183 ( 1987) に記載) 、 group C Streptococcus 由来の Streptococcal FcRc ( US4900660 ( 1985) に記載) 、 group A streptococcus, Type II strain 由来の タンパク質 (US5556944 ( 1991 ) に記載) 、 Human Colonic Mucosal Epithelial Cell 由来のタンパク質 (US6271362 ( 1994) に記載) 、 St叩 hvhcoccus aureus , strain 8325-4 来のタンパク質 (US6548639 ( 1997) に記載) 、 Pseudomonas maltophilia 由来のタンパク質 ( US5245016 ( 1991 ) に記載) 等が知られている。 Staphylococcus aureus-derived Aguchi Aino A (described in A. Forsgren and J. Sjoquist, J. Immunol. (1966) 97, 822-827.), A protein G derived from Streptococus sp.Group CIG (EP013 1 142A2 (1983)) ), Protein L from pg / ο <: ο «:" 5, "agm <.s (described in US5 65390 (1992)), protein H from group AS e /? To" 5 ti (Described in US5 180810 (1993)), Haemophilus influenzae Kamakura's Pine (described in US6025484 (1990)), Septococcwi. AP4-derived protein Arp (Protein Arp 4) (described in US5210183 (1987)) Streptococcal FcRc from group C Streptococcus (described in US4900660 (1985)), protein from group A streptococcus, Type II strain (described in US5556944 (1991)), and protein from Human Colonic Mucosal Epithelial Cell (US6271362 (1994)) Description), St tapping hvhcoccus aureus, protein from strain 8325-4 (described in US6548639 (1997)), derived from Pseudomonas maltophilia Protein (described in US5245016 (1991)) and the like are known.
[0023] また、これらのタンパク質に関しては、多くの場合繰り返し配列を持ち、断片化した タンパク質においても抗体分子との結合能を有することが明らかにされている。本発 明が対象とする抗体分子に結合能を有するタンパク質もしくはペプチドとしては、これ ら天然由来の抗体結合タンパク質、部分タンパク質、その配列改変タンパク質、部分 ペプチド、その模倣ペプチド、抗体分子に結合能を有する人工ペプチドなどが上げ られる。このような抗体分子に結合能を有するタンパク質に関しては、一般式 (6) NH 一 R -COOH (6) [0023] In addition, it has been revealed that these proteins often have a repeating sequence, and fragmented proteins also have an ability to bind to antibody molecules. Examples of the protein or peptide capable of binding to the antibody molecule targeted by the present invention include these naturally occurring antibody binding proteins, partial proteins, their sequence-modified proteins, and partial proteins. Peptides, their mimetic peptides, artificial peptides capable of binding to antibody molecules, and the like can be mentioned. For a protein capable of binding to such an antibody molecule, the general formula (6) NH-R-COOH (6)
2 1 twenty one
[上記式中、 Rは、抗体分子に結合能を有するタンパク質もしくはペプチドのアミノ酸 [In the above formula, R is an amino acid of a protein or peptide capable of binding to an antibody molecule.
1 1
配列を表す] Represents an array]
で表すことができる。 Can be represented by
[0024] 本発明では、一般式 (6) NH -R -COOHで示される結合能を有するタンパク質もしく [0024] In the present invention, a protein or a protein having the binding ability represented by the general formula (6) NH-R-COOH may be used.
2 1 twenty one
はペプチドを固定化できるようにするために、 Is to be able to immobilize the peptide,
一般式 (7) General formula (7)
NH 一 R -CO-NH-R一 CO— NH— CH(CH - SH)— CO— NH— R -COOH (7) NH-R-CO-NH-R-CO-NH-CH (CH-SH) -CO-NH-R-COOH (7)
2 1 2 2 3 で示される固定ィ匕用のタンパク質を作製する必要がある。これらの一般式中、 R It is necessary to prepare a protein for immobilization shown in 2 122. In these general formulas, R
3は 3 is
、中性付近で強く負に荷電し、且つ NH - R -CO-NH-R - CO- NH- CH(CH , Strongly negatively charged near neutral, and NH-R-CO-NH-R-CO-NH-CH (CH
2 1 2 2 2 1 2 2
- SH)-CO-NH-R -COOHの等電点を酸性にできる任意のアミノ酸残基の連鎖を表す -SH) -CO-NH-R -A chain of arbitrary amino acid residues that can make the isoelectric point of -COOH acidic
3 Three
。 R . R
1は、上述の抗体分子に結合能を有するタンパク質もしくはペプチドのアミノ酸配 列である。 R 1 is an amino acid sequence of a protein or peptide capable of binding to the above-mentioned antibody molecule. R
2は、上記一般式 (1)で示される固定ィ匕しょうとするタンパク質と金属表面 上の両親媒性のリンカ一分子との間を延長するリンカ一ペプチドとなる。 R 2 is a linker peptide extending between the protein to be immobilized represented by the general formula (1) and the amphipathic linker molecule on the metal surface. R
2のアミノ酸 配列は任意でありその種類、数ともに限られないが、例えば Gly-Gly-Gly-Gly等を用 いることができる。このような融合タンパク質は、上記一般式 (6)で示されるタンパク質 をコードする遺伝子と The amino acid sequence of 2 is arbitrary and its type and number are not limited. For example, Gly-Gly-Gly-Gly or the like can be used. Such a fusion protein is combined with a gene encoding the protein represented by the general formula (6).
一般式 (8) General formula (8)
NH 一 R -C0-NH-CH(CH 一 SH)— CO— NH— R -COOH (8) NH-R-C0-NH-CH (CH-SH) —CO—NH—R-COOH (8)
2 2 2 3 2 2 2 3
[上記式中、 Rおよび Rは上記の意味を有する。 ] [Wherein, R and R have the above meanings. ]
2 3 twenty three
で示されるペプチド配列をコードする遺伝子とを結合することにより、一般式 (7) NH By binding to a gene encoding a peptide sequence represented by the general formula (7) NH
2 2
— R -CO-NH-R -C0-NH-CH(CH— SH)— C〇— NH— R— C〇〇Hで示される融合タンノ— R -CO-NH-R -C0-NH-CH (CH— SH) — C〇— NH— R— C 融合 H
1 2 2 3 1 2 2 3
ク質をコードする遺伝子を作製し、これを大腸菌などの宿主生物で発現させ、その後 、発現したタンパク質を分離精製することにより得ることができる。 The gene can be obtained by preparing a gene encoding a protein, expressing the gene in a host organism such as Escherichia coli, and then separating and purifying the expressed protein.
[0025] このような融合タンパク質は公知技術(例えば、 M. Iwakura et al., J. Biochem. Ill, 37-45 (1992)参照)を利用することにより、実施することができる。あるいは、上記融合 タンパク質は、遺伝子工学的手法と慣用のタンパク質合成技術との組み合わせ、ま たは、蛋白合成技術のみによっても作製することができる。 [0025] Such a fusion protein can be obtained by a known technique (for example, M. Iwakura et al., J. Biochem. Ill. 37-45 (1992)). Alternatively, the fusion protein can be produced by a combination of a genetic engineering technique and a conventional protein synthesis technique, or by only a protein synthesis technique.
上記一般式 (7)および (8)における Rとしては、ァスパラギン酸やグルタミン酸を多く As for R in the above general formulas (7) and (8), aspartic acid and glutamic acid are often used.
3 Three
含む配列が好適である。好ましくは、上記一般式 (7)および (8)の物質の等電点を 4か ら 5の間の値になるように、ァスパラギン酸やグルタミン酸を多く含む配列をデザイン すればょ 、。そのような配列のうち好適な列としてァラエル-ポリアスパラギン酸をあげ ることができる。シァノシスティン残基の次のアミノ酸残基をァラニンにすることにより、 シァノシスティン残基を介したアミド結合形成反応が生じやす ヽことと、アミノ酸側鎖 の中でァスパラギン酸のカルボキシル基が最も酸性であるからである。 Preferred sequences include. Preferably, a sequence containing a large amount of aspartic acid or glutamic acid should be designed such that the isoelectric points of the substances of the above general formulas (7) and (8) are between 4 and 5. A suitable class of such sequences is Ararael-polyaspartic acid. By changing the amino acid residue next to the cyanocysteine residue to alanine, an amide bond-forming reaction is likely to occur via the cyanocysteine residue, and the carboxyl group of aspartic acid is most frequently present in the amino acid side chains. This is because it is acidic.
[0026] 上記のことを更に具体的に示すため、 Staphylococcus aureus由来のプロテイン Aを 例に以下に説明する。 [0026] In order to more specifically show the above, a description will be given below using Protein A derived from Staphylococcus aureus as an example.
Staphylococcus aureus由来のプロテイン Aは、アミノ酸配列が著しく類似した A,B,C,D,Eと名付けられた 5つのドメインとそれに付随した配列により構成されている 。それらの各々のドメインは、 57アミノ酸で構成されるが、それぞれ単独でも安定な構 造をとり、例えば大腸菌において大量発現させることができる。また、各ドメインは、単 独で抗体分子との結合能を発揮できる。その結合の強さは、天然由来のプロテイン A 全体部分よりも弱まる力 ドメインを 2つ連結したものでは、天然由来のプロテイン A全 体部分とほぼ同程度である。そこで、プロテイン Aのドメインに着目して、単独ドメイン (これをモノマーと称する)とドメインを 2つ連結したもの(これをダイマーと称する)の 2 種類について、固定ィ匕に供するための配列を設計した。 Protein A from Staphylococcus aureus is composed of five domains named A, B, C, D, and E, which have remarkably similar amino acid sequences, and a sequence associated therewith. Each of these domains is composed of 57 amino acids, but each has a stable structure alone and can be expressed in large amounts in, for example, Escherichia coli. In addition, each domain can exert its own binding ability to an antibody molecule. Its binding strength is almost the same as that of the naturally-occurring whole protein A when two force domains that are weaker than the naturally-occurring whole protein A are joined. Therefore, focusing on the domain of protein A, we designed a sequence for immobilization of two types, a single domain (this is called a monomer) and two linked domains (this is called a dimer). did.
[0027] 配列番号 1は、プロテイン Aの Aドメインモノマーを固定ィ匕反応に供するために作製 された固定ィ匕用タンパク質のアミノ酸配列、配列番号 2は、プロテイン Aの Aドメインダ イマ一を固定ィ匕反応に供するために作製された固定ィ匕用タンパク質のアミノ酸配列 を示す。 配列番号 1 [0027] SEQ ID NO: 1 is an amino acid sequence of an immobilization protein prepared for subjecting the A domain monomer of protein A to immobilization reaction. SEQ ID NO: 2 is an immobilization of the A domain monomer of protein A. 2 shows the amino acid sequence of a protein for immobilization prepared for use in the dani reaction. SEQ ID NO: 1
Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie Gin Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ala Glu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie Gin Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ala Glu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp
配列表 2 Sequence Listing 2
Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys
Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu He Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro LysAla Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu He Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys
Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Asp
それぞれの配列は、配列番号 3及び配列番号 4に示される、プロテイン Aの Aドメイ ンモノマー配列及びプロテイン Aの Aドメインダイマー配列のカルボキシ末端側に、 配列番号 5に示す、ポリグリシン システィン残基ーァラニン残基ーポリアスパラギン酸 の配列を付カ卩した配列である。 配列番号 3 The respective sequences are represented by the polyglycine cysteine residue and alanine residue shown in SEQ ID NO: 5 at the carboxy-terminal side of the A domain monomer sequence of protein A and the A domain dimer sequence of protein A shown in SEQ ID NOs: 3 and 4. This is a sequence obtained by adding the sequence of base-polyaspartic acid. SEQ ID NO: 3
Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ala ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys 配列番号 4 Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ala ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys SEQ ID NO: 4
Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu He Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu lie Leu Asn Met Pro Asn Leu Asn Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Ala Asp Asn Asn Phe Asn Lys Glu Gin Gin Asn Ala Phe Tyr Glu He Leu Asn Met Pro Asn Leu Asn Glu Glu Glu Gin Arg Asn Gly Phe lie uln Ser Leu Lys Asp Asp Pro Ser Gin Ser Ala Asn Leu Leu Ser ulu Ala Lys Lys Leu Asn Glu Ser Gin Ala Pro Lys Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Asp
配列番号 5 SEQ ID NO: 5
Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Gly Gly Gly Gly Cys Ala Asp Asp Asp Asp Asp Asp Asp
[0029] 配列番号 5においては、リンカ一部分の配列として、 4個のグリシン残基を示してい るが、リンカ一配列に関しては任意であり、その長さもしくは種類には限定されない。 システィン残基は、側鎖の SH基をシァノ化することにより、シァノシスティンに変換し 、固定ィ匕反応に利用するために必須な残基である。これに引き続くァラニンーポリアス ノ ギン酸の配列は、固定化反応を促進し反応効率を高めるために導入した配列で あり、配列番号 1及び 2に示すタンパク質の等電点を 4から 5の間の値になるようにで きる配列であればどのような配列でも良 、。 [0029] In SEQ ID NO: 5, four glycine residues are shown as the sequence of a part of the linker, but the sequence of the linker is arbitrary and is not limited in length or type. The cysteine residue is an essential residue for converting the SH group in the side chain into a cyanocysteine and utilizing it for the immobilization reaction. The subsequent sequence of alanine-polyasnogic acid was a sequence introduced to promote the immobilization reaction and increase the reaction efficiency, and the isoelectric point of the protein shown in SEQ ID NOS: 1 and 2 was changed from 4 to 5. Any array can be used as long as it can be a value between them.
[0030] 配列番号 1及び配列番号 2に示すタンパク質は、化学合成技術を用いても作製で きるが、配列をコードする遺伝子を大腸菌などの宿主で発現させ、発現細胞から分離 精製することにより得られる。 [0030] The proteins shown in SEQ ID NO: 1 and SEQ ID NO: 2 can also be produced by using a chemical synthesis technique, but are obtained by expressing the gene encoding the sequence in a host such as Escherichia coli and separating and purifying from the expressing cells. Can be
配列番号 1及び配列番号 2に示すタンパク質をコードする配列の例として、それぞ れ配列番号 6及び配列番号 7に示す塩基配列があげることができる。 配列番号 6 Examples of the sequences encoding the proteins shown in SEQ ID NO: 1 and SEQ ID NO: 2 include the nucleotide sequences shown in SEQ ID NO: 6 and SEQ ID NO: 7, respectively. SEQ ID NO: 6
GATGACTAA GATGACTAA
配列番号 7 TGCGCTGATGACGATGACGATGACTAA SEQ ID NO: 7 TGCGCTGATGACGATGACGATGACTAA
[0031] なお、これらの配列表には、開始コドンである ATGと終止コドンである TAAそれぞれ 5 '末端と 3 '末端にカ卩えた配列を示して!/、る。 [0031] These sequence listings show the sequences with ATG as the start codon and TAA as the stop codon at the 5 'end and the 3' end, respectively! /
アミノ酸をコードする塩基配列は縮退しており、複数のコドンがある 1つのアミノ酸残 基に対応することから、配列表 1及び配列表 2に示すタンパク質をコードする配列は、 配列表 6及び配列表 7に限定されず、可能なコドンの組み合わせの数だけ存在する Since the nucleotide sequence encoding an amino acid is degenerate and corresponds to one amino acid residue having multiple codons, the sequences encoding the proteins shown in Sequence Listing 1 and Sequence Listing 2 are shown in Sequence Listing 6 and Sequence Listing. Not limited to 7, but as many as possible codon combinations
[0032] 配列番号 1及び配列番号 2に示すタンパク質をコードする遺伝子配列を大腸菌な どの宿主細胞にぉ 、て発現させるためには、遺伝子の転写及び翻訳に必要な配列 をタンパク質をコードする配列の上流に付けカ卩える必要がある。その様な配列を付け カロえて、ベクターに導入できるようにした遺伝子配列として、例えば、配列番号 8及び 配列番号 9に示す配列がある。 配列番号 8 [0032] In order to express the gene sequence encoding the protein shown in SEQ ID NO: 1 or SEQ ID NO: 2 in a host cell such as Escherichia coli, a sequence necessary for transcription and translation of the gene is replaced with the sequence encoding the protein. It is necessary to add it upstream. Examples of gene sequences which can be added to such a sequence and introduced into a vector include the sequences shown in SEQ ID NO: 8 and SEQ ID NO: 9. SEQ ID NO: 8
配列番号 9 SEQ ID NO: 9
配列番号 10 SEQ ID NO: 10
GCAGCAAAAGGAGGAACGACT に示す配列を開始コドンの上流に結合させると共に、 5'末端に制限酵素 BamHIの認 識切断配列、及び、 3'末端に制限酵素 EcoRIの認識切断配列を結合させ、ベクター DNAに導入できるようにした配列である。 Attach the sequence shown in GCAGCAAAAGGAGGAACGACT upstream of the initiation codon, and connect the recognition cleavage sequence of the restriction enzyme BamHI at the 5 'end and the recognition cleavage sequence of the restriction enzyme EcoRI at the 3' end so that it can be introduced into the vector DNA. Here is the array.
配列番号 8及び配列番号 9に示す配列は、 V、くつかの断片を化学合成した後、 PCR法もしくは DNAリガーゼなどの酵素を用いることにより、人工合成することができ る。 The sequences shown in SEQ ID NO: 8 and SEQ ID NO: 9 can be artificially synthesized by chemically synthesizing V and some fragments, and then using a PCR method or an enzyme such as DNA ligase.
[0034] このようにして得られた合成遺伝子を、制限酵素部位を利用し、適切なベクターに 組み込み、これを宿主細胞中で発現させる。ベクターとしては、適切な制限酵素部位 が利用できるものであれば、どのようなものでも利用できる。例えば、市販品のベクタ 一としては、 pUC系, PBR系の高コピー数ベクターが好適である。配列表 6及び配列表 7を導入した組み換え体を発現させることにより、例えば、大腸菌においては、菌体タ ンパク質の 5から 30%程度にまで、配列表 1及び配列表 2に示すタンパク質を可溶性 の状態で発現 '蓄積させることができる。 [0034] The synthetic gene thus obtained is inserted into an appropriate vector using a restriction enzyme site, and is expressed in a host cell. Any vector can be used as long as an appropriate restriction enzyme site can be used. For example, pUC-type and PBR-type high copy number vectors are suitable as commercially available vectors. By expressing the recombinant into which Sequence Listing 6 and Sequence Listing 7 have been introduced, for example, in E. coli, the proteins shown in Sequence Listing 1 and Sequence Listing 2 can be soluble in about 5 to 30% of the bacterial protein. In the state of 'expression can be accumulated.
[0035] このようにして、発現'蓄積されたタンパク質は、発現菌体の無細胞抽出液から、通 常のタンパク質精製に用いられるクロマトグラフィーの操作により、均一にまで精製す ることができる。用いられるクロマトグラフィーとしては、陰イオン交換クロマトグラフィー 、ゲルろ過クロマトグラフィーなどが有効である力 抗体との結合能を有することから、 ィムノグロブリンを固定ィ匕した担体を利用したァフィ-ティクロマトグラフィーが最も有 効である。 [0035] In this way, the protein which has been expressed and accumulated can be purified to homogeneity from a cell-free extract of the expressed cells by a chromatography operation usually used for protein purification. As the chromatography to be used, anion exchange chromatography, gel filtration chromatography, etc. are effective. Affinity chromatography using a carrier on which immunoglobulin is immobilized is most effective.
[0036] 3.タンパク質のアレイセンサへのスポット法 [0036] 3. Spot method for protein array sensor
次に、本発明においては、上記のようにして調製した固定ィ匕用抗体結合性タンパク 質をタンパク質アレイ用基材に配置、吸着させるが、その方法には特に制限はなぐ 基材上の特定の領域にタンパク質溶液をスポットできる方法であればいかなる方法も 用い得る。例えば、ピン等の針状物、インクジェット、キヤビラリ一等を用いる方法があ る力 いずれの方法を用いてもよい。また、ピッキングロボットを用いることも可能であ る。以下に一例として、キヤピラリーを用いてスポットする方法について詳述する。 Next, in the present invention, the antibody binding protein for immobilization prepared as described above is arranged and adsorbed on a protein array substrate, but the method is not particularly limited. Any method can be used as long as the protein solution can be spotted on the region. For example, there is a method using a needle-like object such as a pin, an ink jet, a capillary, or the like. Any of these methods may be used. It is also possible to use a picking robot. Hereinafter, as an example, a method of spotting using a capillary will be described in detail.
[0037] キヤビラリ一中に、一般式 (7)で示される固定ィ匕用タンパク質の溶液を充填し、上方 力も適当な圧力を加えることによってタンパク質溶液を意図する場所に適量スポット することが可能である。また、固定ィ匕用の基板が吸水性の性質を持つ場合には、 10 μ 1程度の量のタンパク質溶液であれば上カゝら圧力を加えなくても、溶液が基板に迅 速に吸収されていく。その時、タンパク質溶液の溶媒は、スポットされた場所を中心に 全方向に拡散していくが、タンパク質は静電相互作用により一級ァミンに吸着するの で、スポットされた場所に留まる。そのため、タンパク質を小さな領域に高密度で吸着 させることが可能である。更に、スポットする位置を制御することにより、任意のパター ン形状にタンパク質を整列固定ィ匕することができる。このことは、例えば、コンピュータ 上で作図したパターンをインクジェットプリンターで印刷する様にしてコンピュータ制 御により行うこともできる。従って、整列化に用いられる方法ならばどのような方法でも 適用可能であり、このことで本発明が制限を受けないことは自明である。 [0037] A solution of the protein for immobilization represented by the general formula (7) is filled in the capillaries, and an appropriate amount of the protein solution can be spotted at an intended place by applying a suitable pressure to the upward force. is there. When the substrate for immobilization has a water-absorbing property, the solution can be quickly absorbed into the substrate without applying pressure if the protein solution has a volume of about 10 μl. Will be done. At this time, the solvent of the protein solution diffuses in all directions around the spot, but remains at the spot because the protein is adsorbed to primary amine by electrostatic interaction. Therefore, it is possible to adsorb proteins to small regions at high density. Further, by controlling the spotting position, proteins can be aligned and fixed in an arbitrary pattern shape. This can be performed by computer control, for example, by printing a pattern drawn on a computer with an ink jet printer. Therefore, it is obvious that any method used for alignment can be applied, and this does not limit the present invention.
[0038] 4.タンパク質の固定ィ匕 [0038] 4. Protein immobilization
別法として説明するように、上記スポットしたタンパク質を吸着固定化させることによ りそのままタンパク質アレイとしてもよいが、この段階ではあくまでも静電相互作用等 非共有結合によりタンパク質が基材に結合しており、結合強度が低いので、タンパク 質を強固に固定ィ匕するためには、更に、タンパク質のカルボキシ末端のカルボキシ ル基と基材上のポリマーの一級アミノ基との間にアミド結合を形成させる。その反応を 起こさせるためには、固定ィ匕用タンパク質のカルボキシ末端に導入したシスティン残 基のスルフヒドリル基をシァノ化しシァノシスティンに変換する必要がある。 As described as another method, the protein array may be directly formed by adsorbing and immobilizing the spotted proteins, but at this stage, the proteins are bound to the substrate by non-covalent bonds such as electrostatic interactions. Since the bond strength is low, in order to firmly immobilize the protein, an amide bond is further formed between the carboxy group at the carboxy terminus of the protein and the primary amino group of the polymer on the substrate. . In order for this reaction to take place, the cysteine residue introduced at the carboxy terminus of the protein for immobilization was used. The sulfhydryl group of the group needs to be cyanated and converted to cyanocysteine.
[0039] この結合を達成させるためには、上記一般式 (7)のタンパク質中のシスティン残基の スルフヒドリル基をシァノ化しシァノシスティンに変換する必要があり、一般式(7)のシ ァノ化により得られるシァノ化タンパク質は以下の一般式(9)で表されるタンパク質で ある。 In order to achieve this bond, the sulfhydryl group of the cysteine residue in the protein of the general formula (7) needs to be converted to cyanocysteine by converting the sulfhydryl group to a cyanocysteine. The cyanated protein obtained by the conversion is a protein represented by the following general formula (9).
NH— R -CO-NH- R— CO— NH— CH(CH— SCN)— CO— NH— R— COOH · ' ·(9) NH—R—CO-NH—R—CO—NH—CH (CH—SCN) —CO—NH—R—COOH · '· (9)
2 1 2 2 3 2 1 2 2 3
[上記式中、 R、R Rは一般式(7)の R、R Rとそれぞれ同じであり、 Rは任意のアミ [In the above formula, R and R R are the same as R and R R in the general formula (7), respectively.
1 2、 3 1 2、 3 1 1 2, 3 1 2, 3 1
ノ酸配列を、 Rはリンカ一ペプチドを、 Rは中性付近で強く負に荷電しかつ一般式( R is a linker peptide, R is a strongly negative charge near neutrality and R
、 2 3 , twenty three
7)の化合物の等電点を酸性にし得るアミノ酸配列を表す。 ] 7 represents an amino acid sequence capable of making the isoelectric point of the compound of 7) acidic. ]
[0040] このシァノ化反応は、市販のシァノ化試薬を用いて行うことができる。シァノ化試薬 としては、通常、 2-二トロ- 5-チオシァノ安息香酸 (2- nitro- 5- thiocyanobennzoic acid (NTCB》(Y. Degani, A. Ptchornik, Biochemistry, 13,1-11 (1974)参照)または、 1ーシ ァノ- 4-ジメチルァミノピリジ-ゥムテトラフルォロ硼酸 [0040] This cyanation reaction can be performed using a commercially available cyanation reagent. As the cyanating reagent, 2-nitro-5-thiocyanobenzoic acid (NTCB) (see Y.Degani, A. Ptchornik, Biochemistry, 13, 1-11 (1974)) ) Or 1-cyano-4-dimethylaminopyridi-dimethyltetrafluoroboric acid
(1— cyano— 4— dimethylaminopyridinium tetrafluoroborate(CDAP))などを用 V、る方法力 S 簡便である。 (1— cyano— 4-dimethylaminopyridinium tetrafluoroborate (CDAP)) etc.
NTCBを用いたシァノィ匕は、 pH7.0の 10mM燐酸緩衝液中で効率よく行うことができ る。このシァノ化反応の後、溶媒を弱アルカリにすることにより、固定化反応が進行す る。即ち、シァノシスティン残基直前のアミノ酸残基のカルボキシル基と担体の一級 ァミノ基との間にアミド結合が形成される。このことは、緩衝液を pH9.5の 10mM硼酸緩 衝液に換えること等で可能である。 Shiano-dani using NTCB can be performed efficiently in a 10 mM phosphate buffer at pH 7.0. After the cyanation reaction, the fixing reaction proceeds by making the solvent weak alkaline. That is, an amide bond is formed between the carboxyl group of the amino acid residue immediately before the cyanocysteine residue and the primary amino group of the carrier. This can be achieved, for example, by replacing the buffer with a 10 mM boric acid buffer at pH 9.5.
[0041] 上記固定ィ匕反応に必要なシスティン残基のスルフヒドリル基のシァノシスティンの 変換は、既に本発明者らが明らかにしているように、タンパク質を固定ィ匕する基材に 吸着させる前でも、後でも、あるいは吸着と同時に行ってもよい (特願 2002-148950 参照)。一般式 (9)で表されるシァノ化後のタンパク質も中性付近で強く負に帯電す るアミノ酸配列を有しているため、シァノ化後のタンパク質を基材に整列配置、吸着さ せてもタンパク質主鎖のカルボキシ末端側が担体上のポリマー化合物の一級アミノ 基側に吸着し、上記アミド形成反応により、タンパク質主鎖のカルボキシ末端のみで 該一級アミノ基と結合し、これにより、タンパク質を均一な配向状態で、かつ高密度に 整列固定ィ匕されたタンパク質アレイを得ることができる。 [0041] The conversion of the cyanocysteine of the sulfhydryl group of the cysteine residue necessary for the immobilization reaction is carried out before the protein is adsorbed to the substrate on which the immobilization is carried out, as has already been clarified by the present inventors. However, it may be performed later or simultaneously with the adsorption (see Japanese Patent Application No. 2002-148950). Since the protein after cyanation represented by the general formula (9) also has a strongly negatively charged amino acid sequence near neutrality, the protein after cyanation is aligned and adsorbed on a substrate. In addition, the carboxy terminal side of the protein main chain is adsorbed to the primary amino group side of the polymer compound on the carrier, and the amide formation reaction binds to the primary amino group only at the carboxy terminal of the protein main chain, thereby homogenizing the protein. With high alignment and high density A protein array that has been aligned and fixed can be obtained.
[0042] また、本発明で用いるシァノシスティンが関与する反応には、副反応として加水分 解反応が起こりうる力 このような副反応から生成する反応物は全て溶媒に溶けるた め、反応後、タンパク質固定ィ匕反応後のタンパク質アレイを適当な溶媒で洗うことに より副反応生成物を取り除くことができる。 [0042] In the reaction involving cyanocysteine used in the present invention, the potential for a hydrolysis reaction to occur as a side reaction. Since all the reactants generated from such a side reaction are soluble in a solvent, the By washing the protein array after the protein immobilization reaction with an appropriate solvent, side reaction products can be removed.
[0043] 以上、本発明のタンパク質アレイ用基材、及び固定ィ匕用タンパク質を用いて、上記 の操作により固定ィ匕を行うことにより、実施例に示されるように、抗体結合性タンパク 質を数 g/mm2程度の高密度に固定ィ匕した、抗体アレイセンサを作製することができ る。 実施例 As described above, the antibody-binding protein was immobilized on the protein array substrate of the present invention and the immobilizing protein by performing the immobilization by the above-described operation. An antibody array sensor immobilized at a high density of about several g / mm 2 can be produced. Example
[0044] 以下、実施例により本発明を説明するが、本発明はこれらの実施例により限定され ない。 Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited to these examples.
本実施例においては、一級アミンを表面に露出している表面プラズモン共鳴アレイ センサとして、東洋紡製の機器、 Multi SPRinterに付属する NH2—チップあるいは COOH チップを利用し、これを該機器に装着して検討した。これらのチップではそ れぞれ、チップ上の金属表面を 98力所の微小領域に分割し、該領域にアミノ基ある いはカルボキシル基を末端に有し、反対側の末端にチオール基を有するポリエチレ ングリコール (PEG)分子により、単層の安定な SAM表面を用意している。一級アミノ 基を繰り返し構造中に有するポリマー化合物として、シグマ アルドリッチで市販して V、るポリ L リジンを用いた。 In the present embodiment, an NH2-chip or COOH chip attached to Toyobo equipment, Multi SPRinter is used as a surface plasmon resonance array sensor exposing the primary amine on the surface, and this is attached to the equipment. investigated. Each of these chips divides the metal surface on the chip into 98 microscopic areas, each of which has an amino or carboxyl group at the end and a thiol group at the opposite end. Polyethylene glycol (PEG) molecules provide a single layer of stable SAM surface. As a polymer compound having a primary amino group in the repeating structure, poly-L-lysine commercially available from Sigma-Aldrich was used.
[0045] 本実施例において、固定ィ匕に用いるために調製された抗体結合性タンパク質は、 プロテイン A (配列番号 1)に、リンカ一ペプチド部分のアミノ酸配列( [0045] In this example, the antibody-binding protein prepared for use in immobilization was prepared by adding the amino acid sequence of the linker-peptide portion to protein A (SEQ ID NO: 1).
Gly- Gly- Gly- Gly- Gly- Gly)、システィン (Cys)及び中性付近で強く負に荷電し、力 つ得られるタンパク質の等電点を酸性にするためのアミノ酸配列( Gly-Gly-Gly-Gly-Gly-Gly), cysteine (Cys) and an amino acid sequence to strongly acidify the isoelectric point of the resulting strongly charged protein around neutrality (
Ala-Asp-Asp-Asp-Asp-Asp-Asp)が順次付カ卩されたタンパク質(配列番号 2)であり 、これらは、全て先行当該発明者により作製されていたもの(特願 2003-352937に記 載)を用いた。さらにこの結合性タンパク質に固定ィ匕される抗体は、抗ヒッジ IgG抗体 ゥサギ由来抗体 (フナコシ)であり、この抗体が結合された表面へ、抗ゥシ 'アルブミン ヒッジ抗体 (フナコシ)を作用させて、反応を観測した。 Ala-Asp-Asp-Asp-Asp-Asp-Asp) are sequentially added proteins (SEQ ID NO: 2), all of which have been prepared by the present inventor (Japanese Patent Application No. 2003-352937). Described in). Further, the antibody immobilized on the binding protein is an anti-hige IgG antibody. This antibody was derived from a heron (Funakoshi), and the reaction was observed by applying an anti-Pein 'albumin hidge antibody (Funakoshi) to the surface to which this antibody was bound.
[0046] 〔実施例 1〕 Example 1
〔l〕COOH チップを用いた比較実験のための抗体分子直接非配向固定ィ匕により構 築した従来型アレイセンサの作製 [L] Fabrication of a conventional array sensor constructed by direct non-alignment immobilization of antibody molecules for comparative experiments using COOH chips
COOH—チップ上に 0.2 M EDC COOH—0.2 M EDC on chip
(N-ethyl-N ' -[3-(dimethylamino)propyl]carbodiimide)/ 0.05 M NHS (N-ethyl-N '-[3- (dimethylamino) propyl] carbodiimide) /0.05M NHS
(N-Hydroxysuccinimide)の混和水溶液を全体を覆うように滴下して 1時間静置し、表 面カルボン酸を活性ィ匕させた。純水にて表面をすすいだ後、 HEPES緩衝液 (0.05M HEPES (pH 7.4) + 0.2 M NaCl)に溶解させた 100 μ g/mL抗ヒッジ IgG抗体ゥサギ由 来抗体を滴下して 2時間作用させた。純水にて表面をすすいだ後、 1.0Mエタノール ァミン塩酸塩水溶液 (pH 8.5)を 30分作用させ、未反応カルボン酸活性化体を不活性 化した。 A mixed aqueous solution of (N-Hydroxysuccinimide) was dropped so as to cover the whole, and allowed to stand for 1 hour to activate the surface carboxylic acid. After rinsing the surface with pure water, 100 μg / mL anti-hidge IgG antibody dissolved in HEPES buffer (0.05 M HEPES (pH 7.4) + 0.2 M NaCl) was dropped for 2 hours. I let it. After rinsing the surface with pure water, a 1.0 M aqueous solution of ethanolamine hydrochloride (pH 8.5) was allowed to act for 30 minutes to inactivate the unreacted carboxylic acid activated compound.
[0047] 〔2〕 COOH チップとポリマーを用いた抗体分子直接配向固定ィ匕による本発明のァレ ィセンサの作製 [2] Preparation of the array sensor of the present invention by direct antibody molecule orientation fixation using a COOH chip and a polymer
COOH—チップ上に 0.2 M EDC COOH—0.2 M EDC on chip
(N-ethyl-N ' -[3-(dimethylamino)propyl]carbodiimide)/ 0.05 M NHS (N-ethyl-N '-[3- (dimethylamino) propyl] carbodiimide) /0.05M NHS
(N- Hydroxysuccinimide)の混和水溶液を、全体を覆うように滴下して 1時間静置し、 表面カルボン酸を活性ィ匕させた。純水にて表面をすすいだ後、 1 %のポリ L リジン( 分子量: 15万一 30万)を含む水溶液を、東洋紡製のピン型自動スポッティング装置を 用いて、表面プラズモン共鳴アレイセンサの微小領域にスポッティングし、密閉した 容器の中で湿度を 80%に保つことにより、 2時間静置した。 1.0M KC1にて表面を 5回 洗浄した後、 1.0 Mエタノールァミン塩酸塩水溶液 (pH 8.5)を 30分作用させ、未反応 カルボン酸活性ィ匕体を不活性ィ匕した。このように構築したポリマー修飾済の SPRセン サチップを Multi SPRinterのフローセルに装着し、 10 g/mLの末端に負に荷電する アミノ酸とシスティン残基をカ卩えた組換えプロテイン A分子をフローセル中に 1時間通 液循環させ、イオン的相互作用によるタンパク質末端とポリマー中の一級アミノ基との 結合を促進した。この後 5mM NTCB溶液 (pH 7.0)を 1時間通液循環させてプロテイン A中のシスティン残基をシァノ化した後、 10 mM硼酸緩衝液 (pH 9.5)を 1時間通液循 環させてシァノ化システィン残基を介したプロテイン Aタンパク質の C末端の主鎖固 定化反応を促進させた。最後に 1.0M KC1にて表面を 5回洗浄して共有結合が形成 できなかった未反応タンパク質を洗!、流してアレイセンサ基材を作製した。この基材 をフローセル内にとどめたまま、 10 /z g/mL抗ヒッジ IgG抗体ゥサギ由来抗体を通液 循環させて、表面のプロテイン A分子に結合させることにより、本発明による表面ブラ ズモン共鳴抗体アレイセンサを完成させた。 A mixed aqueous solution of (N-Hydroxysuccinimide) was dropped so as to cover the whole and allowed to stand for 1 hour to activate the surface carboxylic acid. After rinsing the surface with pure water, an aqueous solution containing 1% poly-L-lysine (molecular weight: 150,000 to 300,000) was applied to a small area of the surface plasmon resonance array sensor using a pin-type automatic spotting device manufactured by Toyobo. And kept for 2 hours by keeping the humidity at 80% in a sealed container. After washing the surface with 1.0 M KC1 five times, a 1.0 M ethanolamine hydrochloride aqueous solution (pH 8.5) was allowed to act for 30 minutes to inactivate the unreacted carboxylic acid-activated amide. A polymer-modified SPR sensor chip constructed in this way was mounted on a Multi SPRinter flow cell, and a recombinant protein A molecule containing 10 g / mL of negatively charged amino acids and cysteine residues was added to the flow cell. The liquid was circulated for 1 hour to promote the binding between the protein terminal and the primary amino group in the polymer by ionic interaction. Thereafter, a 5 mM NTCB solution (pH 7.0) was circulated for 1 hour to After cyanating the cysteine residue in A, the solution is circulated through a 10 mM borate buffer (pH 9.5) for 1 hour to immobilize the C-terminal backbone of the protein A protein via the cyanated cysteine residue. The reaction was accelerated. Finally, the surface was washed 5 times with 1.0M KC1 to wash unreacted proteins that could not form a covalent bond! While the substrate is kept in the flow cell, the surface plasmon resonance antibody array according to the present invention is obtained by circulating 10 / zg / mL anti-hidden IgG antibody and a heron-derived antibody to bind to the protein A molecule on the surface. The sensor was completed.
[0048] 〔3〕従来型ならびに本発明による抗体アレイセンサの性能比較試験 [3] Performance comparison test of conventional and antibody array sensors according to the present invention
上記〔1〕、〔2〕でそれぞれ作成した従来法ならびに本発明による表面プラズモン共鳴 抗体アレイセンサを比較するため、 2つのアレイセンサを別途フローセルに納め、 10 IX g/mL抗ゥシ ·アルブミンヒッジ抗体 (フナコシ)を通液循環により作用させて反応を 観測した (図 1)。図から明快なように、従来型の固定ィ匕法 (非配向)にて抗体分子を 固定化させた表面(図中曲線 A)では、検出限界に近!、小さなシグナルし力観測でき なったが、本発明によるアレイセンサ(図中曲線 B)では、配向制御固定ィ匕法による実 効感度の向上を反映して遙かに大きなシグナルが観測されており、本発明による表 面プラズモン共鳴アレイセンサ構築技術の妥当性を示している。 In order to compare the surface plasmon resonance antibody array sensor according to the present invention and the conventional method prepared in the above [1] and [2], two array sensors were separately placed in a flow cell and 10 IX g / mL anti-albumin hitch was used. The reaction was observed by applying diantibodies (Funakoshi) through liquid circulation (Fig. 1). As is clear from the figure, on the surface (curve A in the figure) on which the antibody molecules were immobilized by the conventional immobilization method (non-oriented), the detection limit was reached! However, in the array sensor according to the present invention (curve B in the figure), a much larger signal was observed reflecting the improvement in the effective sensitivity due to the orientation control fixing method, and the surface plasmon resonance array according to the present invention was observed. This shows the validity of the sensor construction technology.
図面の簡単な説明 Brief Description of Drawings
[0049] [図 1]図 1は、従来法ならびに本発明により、表面プラズモン共鳴抗体アレイセンサに 抗ヒッジ IgG抗体ゥサギ由来抗体をそれぞれ固定ィ匕し、 10 g/mL抗ゥシ ·アルブミ ンヒッジ抗体 (フナコシ)を作用させて反応を観測した図である。縦軸は表面ブラズモ ン共鳴のシグナル値で、横軸は時間である。太い横線はフローセルに 10 g/mL抗ゥ シ ·アルブミンヒッジ抗体 (フナコシ)を通液循環させた時間をそれぞれ示し、それ以 外の時間は HEPES緩衝液を通液循環させた。 [FIG. 1] FIG. 1 shows that a surface plasmon resonance antibody array sensor was immobilized with an anti-hidden IgG antibody and a heron-derived antibody according to the conventional method and the present invention, respectively, and a 10 g / mL anti-human albumin antibody was detected. FIG. 3 is a diagram in which a reaction was observed with (Funakoshi) acting. The vertical axis is the signal value of surface plasmon resonance, and the horizontal axis is time. Thick horizontal lines indicate the time during which 10 g / mL anti-serum / albumin antibody (Funakoshi) was circulated through the flow cell, and during the other times, the HEPES buffer was circulated.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-030700 | 2004-02-06 | ||
| JP2004030700A JP3937020B2 (en) | 2004-02-06 | 2004-02-06 | Surface plasmon resonance antibody array sensor fabrication substrate and fabrication method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2005075996A1 true WO2005075996A1 (en) | 2005-08-18 |
Family
ID=34836012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2005/001579 Ceased WO2005075996A1 (en) | 2004-02-06 | 2005-02-03 | Baseboard for constructing surface plasmon resonane antibody array sensor and method of constructing the same |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP3937020B2 (en) |
| WO (1) | WO2005075996A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697349B2 (en) | 2007-11-01 | 2014-04-15 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Method of producing solid-phase body having immobilized microobject and the use thereof |
| EP3462174A3 (en) * | 2013-03-15 | 2019-05-22 | Arizona Board of Regents on behalf of Arizona State University | Biosensor microarray compositions and methods |
| CN110221059A (en) * | 2019-07-18 | 2019-09-10 | 大连理工大学 | Method for regulating and controlling HCG antibody orientation on surface of silicon nano material |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070196233A1 (en) | 2006-02-23 | 2007-08-23 | Fujifilm Corporation | Biosensor and method for immobilizing a physiologically active substance |
| JP5026815B2 (en) * | 2006-02-23 | 2012-09-19 | 富士フイルム株式会社 | Biosensor and method for immobilizing physiologically active substance |
| JP5004166B2 (en) * | 2006-10-10 | 2012-08-22 | 独立行政法人産業技術総合研究所 | Protein-immobilized carrier suitable for protein orientation control immobilization |
| JP5008027B2 (en) * | 2006-10-10 | 2012-08-22 | 独立行政法人産業技術総合研究所 | Method for designing a protein suitable for protein orientation control immobilization |
| JP5004165B2 (en) * | 2006-10-10 | 2012-08-22 | 独立行政法人産業技術総合研究所 | Protein suitable for protein orientation control immobilization |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503066A (en) * | 1992-08-10 | 1996-04-02 | モーリトセン・アンド・エルスナー・エー/エス | Method of chemical bonding to solid phase |
| JP2000247999A (en) * | 1999-02-26 | 2000-09-12 | Agency Of Ind Science & Technol | Production of immobilized protein |
| JP2003528301A (en) * | 2000-03-22 | 2003-09-24 | インサイト・ゲノミックス・インコーポレイテッド | Polymer Coated Surface for Microarray Applications |
-
2004
- 2004-02-06 JP JP2004030700A patent/JP3937020B2/en not_active Expired - Lifetime
-
2005
- 2005-02-03 WO PCT/JP2005/001579 patent/WO2005075996A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503066A (en) * | 1992-08-10 | 1996-04-02 | モーリトセン・アンド・エルスナー・エー/エス | Method of chemical bonding to solid phase |
| JP2000247999A (en) * | 1999-02-26 | 2000-09-12 | Agency Of Ind Science & Technol | Production of immobilized protein |
| JP2003528301A (en) * | 2000-03-22 | 2003-09-24 | インサイト・ゲノミックス・インコーポレイテッド | Polymer Coated Surface for Microarray Applications |
Non-Patent Citations (4)
| Title |
|---|
| ASO ET AL: "Aminoalkanethiol o Riyo shita Kotai Koteika to SPR Men'eki Sensing eno Oyo.", THE CHEMICAL SOCIETY OF JAPAN, BIOTECHNOLOGY BUKAI SYMPOSIUM KOEN YOSHISHU., 2001, pages 27, XP002997258 * |
| CHOU S.F. ET AL: "Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance.", BIOSENS BIOELECTRON., vol. 19, no. 9, 15 April 2004 (2004-04-15), pages 999 - 1005, XP002997261 * |
| LEE W. ET AL: "Fabrication of self-assembled protein A monolayer and its application as an immonosensor.", BIOSENS BIOELECTRON., vol. 19, no. 3, 30 November 2003 (2003-11-30), pages 185 - 192, XP002997259 * |
| QUINN J. ET AL: "The use of regenerable, affinity ligand-based surface for immunosensor applications.", BIOSENS BIOELECTRON., vol. 14, no. 6, 30 June 1999 (1999-06-30), pages 587 - 595, XP002997260 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697349B2 (en) | 2007-11-01 | 2014-04-15 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Method of producing solid-phase body having immobilized microobject and the use thereof |
| EP3462174A3 (en) * | 2013-03-15 | 2019-05-22 | Arizona Board of Regents on behalf of Arizona State University | Biosensor microarray compositions and methods |
| US10983118B2 (en) | 2013-03-15 | 2021-04-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Biosensor microarray compositions and methods |
| US11828753B2 (en) | 2013-03-15 | 2023-11-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Biosensor microarray compositions and methods |
| CN110221059A (en) * | 2019-07-18 | 2019-09-10 | 大连理工大学 | Method for regulating and controlling HCG antibody orientation on surface of silicon nano material |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005221423A (en) | 2005-08-18 |
| JP3937020B2 (en) | 2007-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Advances in epitope molecularly imprinted polymers for protein detection: a review | |
| Khumsap et al. | Epitope-imprinted polymers: applications in protein recognition and separation | |
| CN103348244B (en) | With the oligopeptide sequence of phenylboric acid base specific binding | |
| US20060014232A1 (en) | Immobilization method | |
| EP2205641B1 (en) | Method for preparing antibody monolayers which have controlled orientation using peptide hybrid | |
| Löfås et al. | The art of immobilization for SPR sensors | |
| JP4006523B2 (en) | Protein array and production method thereof | |
| JP2005513503A (en) | Immobilization of binding substances | |
| JP5963248B2 (en) | Antibody purification carrier, production method thereof and use thereof | |
| JP3937020B2 (en) | Surface plasmon resonance antibody array sensor fabrication substrate and fabrication method thereof | |
| WO2018154814A1 (en) | Biomaterial immobilizing method and uses thereof | |
| JP3740529B2 (en) | Method for immobilizing protein with controlled orientation and method for aligning and immobilizing protein using the same | |
| JP6103772B2 (en) | IgA-binding peptide and purification of IgA thereby | |
| JP5392682B2 (en) | Immobilized protein | |
| JP4853971B2 (en) | Method for producing sensing chip for target molecule | |
| JP2005112827A (en) | Antibody affinity carrier | |
| JP4846803B2 (en) | New capture agent for ligand binding | |
| KR100877187B1 (en) | Diagnostic protein chip comprising protein nanoparticles linked to disease marker epitopes and ultra-sensitive detection methods thereof | |
| AU2001287451A1 (en) | Biosensor assay device and method | |
| US20050042598A1 (en) | Method for identifying interaction partners using phage display | |
| JP5392683B2 (en) | Activating carrier for preparing immobilized protein | |
| WO2005022156A1 (en) | Method of protein immobilization | |
| JP4922341B2 (en) | Target recognition molecule and method for immobilizing the target recognition molecule | |
| JP5392684B2 (en) | Method for producing immobilized protein | |
| Cooper | Sensor surfaces and receptor deposition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase |